

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in the understanding of renal... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-874/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-874" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis.">
            <meta name="og:description" content="Read the latest article version by Susan Yung, Desmond YH Yap, Tak Mao Chan, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="11255">
            <meta name="article-id" content="10445">
            <meta name="dc.title" content="Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis">
            <meta name="dc.description" content="Lupus nephritis is a potentially reversible cause of severe acute kidney injury and is an important cause of end-stage renal failure in Asians and patients of African or Hispanic descent. It is characterized by aberrant exaggerated innate and adaptive immune responses, autoantibody production and their deposition in the kidney parenchyma, triggering complement activation, activation and proliferation of resident renal cells, and expression of pro-inflammatory and chemotactic molecules leading to the influx of inflammatory cells, all of which culminate in destruction of normal nephrons and their replacement by fibrous tissue. Anti-double-stranded DNA (anti-dsDNA) antibody level correlates with disease activity in most patients. There is evidence that apart from mediating pathogenic processes through the formation of immune complexes, pathogenic anti-dsDNA antibodies can bind to resident renal cells and induce downstream pro-apoptotic, pro-inflammatory, or pro-fibrotic processes or a combination of these. Recent data also highlight the critical role of macrophages in acute and chronic kidney injury. Though clinically effective, current treatments for lupus nephritis encompass non-specific immunosuppression and the anti-inflammatory action of high-dose corticosteroids. The clinical and histological impact of novel biologics targeting pro-inflammatory molecules remains to be investigated. Insight into the underlying mechanisms that induce inflammatory and fibrotic processes in the kidney of lupus nephritis could present opportunities for more specific novel treatment options to improve clinical outcomes while minimizing off-target untoward effects. This review discusses recent advances in the understanding of pathogenic mechanisms leading to inflammation and fibrosis of the kidney in lupus nephritis in the context of established standard-of-care and emerging therapies.">
            <meta name="dc.subject" content="Lupus nephritis, AKI, acute kidney injury, renal failure, SLE">
            <meta name="dc.creator" content="Yung, Susan">
            <meta name="dc.creator" content="Yap, Desmond YH">
            <meta name="dc.creator" content="Chan, Tak Mao">
            <meta name="dc.date" content="2017/06/13">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.10445.1">
            <meta name="dc.source" content="F1000Research 2017 6:874">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Lupus nephritis">
            <meta name="prism.keyword" content="AKI">
            <meta name="prism.keyword" content="acute kidney injury">
            <meta name="prism.keyword" content="renal failure">
            <meta name="prism.keyword" content="SLE">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/06/13">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="874">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.10445.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-874">
            <meta name="citation_title" content="Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis">
            <meta name="citation_abstract" content="Lupus nephritis is a potentially reversible cause of severe acute kidney injury and is an important cause of end-stage renal failure in Asians and patients of African or Hispanic descent. It is characterized by aberrant exaggerated innate and adaptive immune responses, autoantibody production and their deposition in the kidney parenchyma, triggering complement activation, activation and proliferation of resident renal cells, and expression of pro-inflammatory and chemotactic molecules leading to the influx of inflammatory cells, all of which culminate in destruction of normal nephrons and their replacement by fibrous tissue. Anti-double-stranded DNA (anti-dsDNA) antibody level correlates with disease activity in most patients. There is evidence that apart from mediating pathogenic processes through the formation of immune complexes, pathogenic anti-dsDNA antibodies can bind to resident renal cells and induce downstream pro-apoptotic, pro-inflammatory, or pro-fibrotic processes or a combination of these. Recent data also highlight the critical role of macrophages in acute and chronic kidney injury. Though clinically effective, current treatments for lupus nephritis encompass non-specific immunosuppression and the anti-inflammatory action of high-dose corticosteroids. The clinical and histological impact of novel biologics targeting pro-inflammatory molecules remains to be investigated. Insight into the underlying mechanisms that induce inflammatory and fibrotic processes in the kidney of lupus nephritis could present opportunities for more specific novel treatment options to improve clinical outcomes while minimizing off-target untoward effects. This review discusses recent advances in the understanding of pathogenic mechanisms leading to inflammation and fibrosis of the kidney in lupus nephritis in the context of established standard-of-care and emerging therapies.">
            <meta name="citation_description" content="Lupus nephritis is a potentially reversible cause of severe acute kidney injury and is an important cause of end-stage renal failure in Asians and patients of African or Hispanic descent. It is characterized by aberrant exaggerated innate and adaptive immune responses, autoantibody production and their deposition in the kidney parenchyma, triggering complement activation, activation and proliferation of resident renal cells, and expression of pro-inflammatory and chemotactic molecules leading to the influx of inflammatory cells, all of which culminate in destruction of normal nephrons and their replacement by fibrous tissue. Anti-double-stranded DNA (anti-dsDNA) antibody level correlates with disease activity in most patients. There is evidence that apart from mediating pathogenic processes through the formation of immune complexes, pathogenic anti-dsDNA antibodies can bind to resident renal cells and induce downstream pro-apoptotic, pro-inflammatory, or pro-fibrotic processes or a combination of these. Recent data also highlight the critical role of macrophages in acute and chronic kidney injury. Though clinically effective, current treatments for lupus nephritis encompass non-specific immunosuppression and the anti-inflammatory action of high-dose corticosteroids. The clinical and histological impact of novel biologics targeting pro-inflammatory molecules remains to be investigated. Insight into the underlying mechanisms that induce inflammatory and fibrotic processes in the kidney of lupus nephritis could present opportunities for more specific novel treatment options to improve clinical outcomes while minimizing off-target untoward effects. This review discusses recent advances in the understanding of pathogenic mechanisms leading to inflammation and fibrosis of the kidney in lupus nephritis in the context of established standard-of-care and emerging therapies.">
            <meta name="citation_keywords" content="Lupus nephritis, AKI, acute kidney injury, renal failure, SLE">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Susan Yung">
            <meta name="citation_author_institution" content="Department of Medicine, University of Hong Kong, Hong Kong, Hong Kong">
            <meta name="citation_author" content="Desmond YH Yap">
            <meta name="citation_author_institution" content="Department of Medicine, University of Hong Kong, Hong Kong, Hong Kong">
            <meta name="citation_author" content="Tak Mao Chan">
            <meta name="citation_author_institution" content="Department of Medicine, University of Hong Kong, Hong Kong, Hong Kong">
            <meta name="citation_publication_date" content="2017/06/13">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="874">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.10445.1">
            <meta name="citation_firstpage" content="874">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-874/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-874.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=11255 /> <input type=hidden id=articleId name=articleId value=10445 /> <input type=hidden id=xmlUrl value="/articles/6-874/v1/xml"/> <input type=hidden id=xmlFileName value="-6-874-v1.xml"> <input type=hidden id=article_uuid value=cec0a1fd-1661-4ff5-9835-797f9b49da49 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.10445.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.10445.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-874"
  },
  "headline": "Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis",
  "datePublished": "2017-06-13T10:27:34",
  "dateModified": "2017-06-13T10:27:34",
  "author": [
    {
      "@type": "Person",
      "name": "Susan Yung"
    },    {
      "@type": "Person",
      "name": "Desmond YH Yap"
    },    {
      "@type": "Person",
      "name": "Tak Mao Chan"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Lupus nephritis is a potentially reversible cause of severe acute kidney injury and is an important cause of end-stage renal failure in Asians and patients of African or Hispanic descent. It is characterized by aberrant exaggerated innate and adaptive immune responses, autoantibody production and their deposition in the kidney parenchyma, triggering complement activation, activation and proliferation of resident renal cells, and expression of pro-inflammatory and chemotactic molecules leading to the influx of inflammatory cells, all of which culminate in destruction of normal nephrons and their replacement by fibrous tissue. Anti-double-stranded DNA (anti-dsDNA) antibody level correlates with disease activity in most patients. There is evidence that apart from mediating pathogenic processes through the formation of immune complexes, pathogenic anti-dsDNA antibodies can bind to resident renal cells and induce downstream pro-apoptotic, pro-inflammatory, or pro-fibrotic processes or a combination of these. Recent data also highlight the critical role of macrophages in acute and chronic kidney injury. Though clinically effective, current treatments for lupus nephritis encompass non-specific immunosuppression and the anti-inflammatory action of high-dose corticosteroids. The clinical and histological impact of novel biologics targeting pro-inflammatory molecules remains to be investigated. Insight into the underlying mechanisms that induce inflammatory and fibrotic processes in the kidney of lupus nephritis could present opportunities for more specific novel treatment options to improve clinical outcomes while minimizing off-target untoward effects. This review discusses recent advances in the understanding of pathogenic mechanisms leading to inflammation and fibrosis of the kidney in lupus nephritis in the context of established standard-of-care and emerging therapies."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-874.html",
            "name": "Recent advances in the understanding of renal inflammation and fibrosis..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in the understanding of renal inflammation and fibrosis... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=11255 data-id=10445 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10445.1" data-recommended="" data-doi="10.12688/f1000research.10445.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-874/v1/pdf?article_uuid=cec0a1fd-1661-4ff5-9835-797f9b49da49" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-10445-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-10445-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-10445-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Yung S, Yap DY and Chan TM. Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):874 (<a class=new-orange href="https://doi.org/10.12688/f1000research.10445.1" target=_blank>https://doi.org/10.12688/f1000research.10445.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-10445-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=10445 id=track-article-signin-10445 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10445?target=/articles/6-874.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=11255 /> <input name=articleId type=hidden value=10445 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Susan Yung,&nbsp;</span><span class="">Desmond YH Yap,&nbsp;</span><span class=""><a href="mailto:dtmchan@hku.hk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Tak Mao Chan</span></a><a href="https://orcid.org/0000-0002-3495-4051" target=_blank id=author-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-3495-4051</div></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Susan Yung,&nbsp;</span><span class="">Desmond YH Yap,&nbsp;</span><span class=""><a href="mailto:dtmchan@hku.hk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Tak Mao Chan</span></a><a href="http://orcid.org/0000-0002-3495-4051" target=_blank id=mauthor-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-3495-4051</div></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 13 Jun 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.10445.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Medicine, University of Hong Kong, Hong Kong, Hong Kong<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=23568-23440></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=10890-23441></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Lupus nephritis is a potentially reversible cause of severe acute kidney injury and is an important cause of end-stage renal failure in Asians and patients of African or Hispanic descent. It is characterized by aberrant exaggerated innate and adaptive immune responses, autoantibody production and their deposition in the kidney parenchyma, triggering complement activation, activation and proliferation of resident renal cells, and expression of pro-inflammatory and chemotactic molecules leading to the influx of inflammatory cells, all of which culminate in destruction of normal nephrons and their replacement by fibrous tissue. Anti-double-stranded DNA (anti-dsDNA) antibody level correlates with disease activity in most patients. There is evidence that apart from mediating pathogenic processes through the formation of immune complexes, pathogenic anti-dsDNA antibodies can bind to resident renal cells and induce downstream pro-apoptotic, pro-inflammatory, or pro-fibrotic processes or a combination of these. Recent data also highlight the critical role of macrophages in acute and chronic kidney injury. Though clinically effective, current treatments for lupus nephritis encompass non-specific immunosuppression and the anti-inflammatory action of high-dose corticosteroids. The clinical and histological impact of novel biologics targeting pro-inflammatory molecules remains to be investigated. Insight into the underlying mechanisms that induce inflammatory and fibrotic processes in the kidney of lupus nephritis could present opportunities for more specific novel treatment options to improve clinical outcomes while minimizing off-target untoward effects. This review discusses recent advances in the understanding of pathogenic mechanisms leading to inflammation and fibrosis of the kidney in lupus nephritis in the context of established standard-of-care and emerging therapies. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Lupus nephritis, AKI, acute kidney injury, renal failure, SLE </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Tak Mao Chan (<a href="mailto:dtmchan@hku.hk">dtmchan@hku.hk</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Tak Mao Chan </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> Studies undertaken by TMC’s group [1, 4, 10, 12, 14–17, 22, 31, 39] were funded by the RGC General Research Fund (HKU 7366/04M, 7550/06M, 7604/10M, HKU 7607/12M, 17100914, and 17126814) and UGC Matching Grant Schemes (Phases IV, V, and VI). SY is supported by the Wai Hung Charitable Foundation Limited and the ‘Yu Chiu Kwong Professorship in Medicine’ Endowment Fund awarded to TMC. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Yung S <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Yung S, Yap DY and Chan TM. Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):874 (<a href="https://doi.org/10.12688/f1000research.10445.1" target=_blank>https://doi.org/10.12688/f1000research.10445.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 13 Jun 2017, <b>6</b>(F1000 Faculty Rev):874 (<a href="https://doi.org/10.12688/f1000research.10445.1" target=_blank>https://doi.org/10.12688/f1000research.10445.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 13 Jun 2017, <b>6</b>(F1000 Faculty Rev):874 (<a href="https://doi.org/10.12688/f1000research.10445.1" target=_blank>https://doi.org/10.12688/f1000research.10445.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d16993e205>Introduction</h2><p class="" id=d16993e208>Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE) and is associated with a sixfold increase in mortality compared with the general population<sup><a href="#ref-1">1</a></sup>. Up to 60% of patients with SLE will develop LN at some stage during the course of disease, the percentage depending on race, ethnicity, and health-care availability<sup><a href="#ref-1">1</a>–<a href="#ref-3">3</a></sup>. LN is characterized by loss of self-tolerance, production of autoantibodies to nuclear autoantigens, immune complex deposition, and immune-mediated injury to the kidney parenchyma. Clinically, LN is characterized by periods of remission interspersed with episodes of disease activity or flares. If these inflammatory processes are not effectively and rapidly controlled, glomerulosclerosis, interstitial fibrosis, tubular atrophy, and progressive kidney failure will follow, leading to end-stage renal failure requiring renal replacement therapy. Treatment of LN has evolved considerably over the past few decades from reliance on corticosteroids alone to different combination immunosuppressive regimens, and the optimal choice is informed by the type and severity of nephritis, the phase in the natural history of disease, and patient characteristics<sup><a href="#ref-4">4</a></sup>. It has been reported that approximately 30% of patients eventually will progress to end-stage renal failure<sup><a href="#ref-3">3</a>,<a href="#ref-5">5</a></sup>. Identifying key elements in the pathogenesis of inflammation and fibrosis or important checkpoints leading to kidney damage could present opportunities for novel means of therapeutic intervention to further improve clinical outcomes.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d16993e236>Overview of lupus nephritis pathogenesis</h2><p class="" id=d16993e239>LN is initiated by the deposition of anti-double-stranded DNA (anti-dsDNA) antibody-containing immune complexes in the kidney parenchyma resulting in complement activation, infiltration of immune cells, increased activation and proliferation of resident renal cells, and immune-mediated kidney injury. The precise location of immune complexes in the glomerulus and tubulo-interstitium, their size, ability to activate complement, and the effectiveness of complex-clearing mechanisms dictate the severity of proliferative and inflammatory responses in the kidney. The glomerulus is the predominant site for immune complex deposition. Deposition within the mesangium is accompanied by mesangial hypercellularity and increased matrix synthesis, whereas their deposition in the subendothelium induces endothelial cell injury, endocapillary proliferation and infiltration of circulating myeloid cells into the kidney<sup><a href="#ref-6">6</a></sup>. Injury to endothelial cells induces the release of apoptotic microparticles that drive dendritic cell activation and prime neutrophils for NETosis, which further exacerbates inflammatory processes<sup><a href="#ref-7">7</a></sup>. Subepithelial deposits promote podocyte injury with restricted immune cell infiltration unless the glomerular basement membrane (GBM) ruptures<sup><a href="#ref-8">8</a></sup>. The most severe forms of LN (classes III and IV) are characterized by inflammatory and proliferative glomerular lesions resulting in fibrosis and loss of renal function<sup><a href="#ref-9">9</a></sup>. Immune deposits have also been detected in the tubular basement membrane in up to 70% of patients with LN, especially those with class III or IV LN, and the quantity of immune complex deposition correlates with the severity of tubulo-interstitial inflammation<sup><a href="#ref-10">10</a>,<a href="#ref-11">11</a></sup>.</p><p class="" id=d16993e265>Anti-dsDNA antibody production is a cardinal feature of LN, and serum levels often correlate with disease activity<sup><a href="#ref-12">12</a>,<a href="#ref-13">13</a></sup>. There is evidence that in addition to contributing to immune complex formation, pathogenic anti-dsDNA antibodies can bind to resident renal cells and induce downstream apoptotic, inflammatory, and fibrotic processes<sup><a href="#ref-10">10</a>,<a href="#ref-12">12</a>,<a href="#ref-14">14</a>–<a href="#ref-20">20</a></sup>. There is increasing evidence to suggest that the pathogenic potential of anti-dsDNA antibodies is not dependent on its interaction with dsDNA per se since dsDNA is poorly immunogenic<sup><a href="#ref-21">21</a></sup> but is instead reliant on its poly-reactive nature and ability to bind to cross-reactive antigens on the surface of resident renal cells or constituents of their extracellular matrix<sup><a href="#ref-22">22</a>–<a href="#ref-24">24</a></sup>. Many of the studies relating to anti-dsDNA antibodies binding to resident renal cells have focused on mesangial cells and currently there are limited data on the interaction of anti-dsDNA antibodies with glomerular endothelial cells, podocytes, and proximal tubular epithelial cells (PTECs). Anti-dsDNA antibodies have also been reported to bind to nucleosomes that are released into the circulation from either circulating or intra-glomerular apoptotic cells, which are then entrapped within the GBM. Recently, Olin <i>et al</i>. demonstrated that laminin β1, an extracellular matrix component induced in resident renal cells by transforming growth factor-beta 1 (TGF-β1) during tissue fibrosis, entrapped nucleosomes in electron-dense deposits in the GBM which could serve as antigens for anti-dsDNA antibodies<sup><a href="#ref-25">25</a></sup>. Although there has been much debate on the mechanisms that mediate anti-dsDNA antibody binding to the kidney parenchyma, distinct mechanisms may operate in different renal compartments and possibly at different phases of disease.</p><p class="" id=d16993e307>The pathogenic mechanisms of anti-dsDNA antibodies remain controversial. Non-dsDNA-binding antibodies may also contribute to kidney injury. Dissociation between anti-dsDNA antibody deposition and LN has also been reported in experimental models of LN. In NZM2328.Lc4 mice, intra-glomerular immune complex deposition and fatal LN occurred in the absence of anti-dsDNA antibodies<sup><a href="#ref-26">26</a></sup>. Furthermore, lupus-prone mice deficient in Stat4, a transcription factor that drives Th1 responses, displayed accelerated nephritis compared with their wild-type littermates in the absence of anti-dsDNA antibodies<sup><a href="#ref-27">27</a></sup>. The mode of kidney inflammation could be more important than anti-dsDNA antibodies per se in the initiation and progression of LN<sup><a href="#ref-27">27</a></sup>. Biopsy-proven LN can occur in patients without anti-dsDNA antibodies in the circulation<sup><a href="#ref-28">28</a></sup>. Discordance between circulating anti-dsDNA antibody titres and activity of LN may also be attributed to the different dsDNA substrates used in immunoassays<sup><a href="#ref-29">29</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d16993e333>Recent knowledge on renal inflammation in lupus nephritis</h2><div class=section><a name=d16993e336 class=n-a></a><h3 class=section-title>(a) Role of resident kidney cells</h3><p class="" id=d16993e341>The mesangium is the site for anti-dsDNA antibody-containing immune complex deposition in the glomerulus in less severe forms of LN, and mesangial immune deposits are always present in severe nephritis. We<sup><a href="#ref-22">22</a></sup> and others<sup><a href="#ref-23">23</a>,<a href="#ref-30">30</a></sup> have reported that anti-dsDNA antibodies can bind directly to mesangial cells through cell surface annexin II or α-actinin. The functional consequence of anti-dsDNA antibody binding to α-actinin on mesangial cells has not been defined. Binding of anti-dsDNA antibodies to mesangial annexin II resulted in the activation of mitogen-activated protein kinase (MAPK) and AKT/phosphoinositide 3-kinase (AKT/PI3K) signaling pathways and increased IL-6 secretion and annexin II expression. That anti-dsDNA antibodies can augment increased annexin II expression in mesangial cells suggests potential amplification of immune-mediated inflammation in the glomerulus<sup><a href="#ref-22">22</a></sup>. At the ultrastructural level, annexin II localized to the surface of mesangial cells and in the mesangial matrix and also with electron-dense immune deposits along the GBM<sup><a href="#ref-31">31</a></sup>. Annexin II can co-localize with immunoglobulin G (IgG) and complement 3 (C3) deposition in human and murine LN, thus underscoring the pathogenic role of annexin II and its interaction with anti-dsDNA antibodies in LN<sup><a href="#ref-22">22</a></sup>. Anti-dsDNA antibodies can induce gene or protein expression (or both) of pro-inflammatory mediators such as interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), hyaluronan, lipocalin-2, monocyte chemoattractant protein-1 (MCP-1), (C-X-C motif) ligand 1 (CXCL1)/KC, CX3CL, and inducible nitric oxide synthase in cultured human or murine mesangial cells<sup><a href="#ref-15">15</a>,<a href="#ref-17">17</a>,<a href="#ref-22">22</a>,<a href="#ref-32">32</a></sup>. The induction of these pro-inflammatory mediators is facilitated through the binding of high-mobility group box 1 protein, engagement of Toll-like receptor 2 (TLR-2) and receptor for advanced glycation end-products (RAGE), activation of the MAPK, protein kinase C (PKC), inhibitor of kappa-light chain-enhancer of activated B cells (IκB) and nuclear factor kappa B (NF-κB) signaling pathways, and endoplasmic reticulum stress<sup><a href="#ref-20">20</a>,<a href="#ref-32">32</a>–<a href="#ref-35">35</a></sup>. Correlation between serum levels of IL-1β, IL-6, TNF-α, hyaluronan, and lipocalin and disease activity in patients with SLE further highlights the importance of these inflammatory markers in the pathogenesis of LN<sup><a href="#ref-17">17</a>,<a href="#ref-36">36</a>–<a href="#ref-39">39</a></sup>.</p><p class="" id=d16993e401>The severity of tubulo-interstitial inflammation and injury strongly correlates with poor renal prognosis<sup><a href="#ref-40">40</a></sup>. We reported that anti-dsDNA antibodies isolated from patients with LN during nephritic flare can induce secretion of pro-inflammatory mediators such as IL-6, IL-8, TNF-α, and MCP-1 through distinct MAPK pathways in cultured PTECs<sup><a href="#ref-14">14</a>,<a href="#ref-39">39</a></sup> and contribute to the establishment of chemotactic gradients that permit infiltration of immune cells into the tubulo-interstitium. Bi-directional communication occurs between mesangial cells and PTECs, and inflammatory responses occurring in either kidney compartment induced by anti-dsDNA antibodies can provoke a response in the other compartment<sup><a href="#ref-10">10</a></sup>. Anti-dsDNA antibodies isolated from LN patients in remission can also induce IL-6 secretion in PTECs<sup><a href="#ref-10">10</a></sup>, a pro-inflammatory cytokine that promotes B-cell differentiation and autoantibody production. Increased IL-6 expression is observed in the kidneys of patients and mice with LN, and infiltrating monocytes/macrophages, mesangial cells, and PTECs are thought to be the predominant source. The findings suggest the possibility of subclinical inflammation, which has important implications on the choice and dose of maintenance immunosuppressive therapy. Current methods for monitoring disease activity do not reliably assess kidney inflammation and fibrosis, and the search for biomarkers which could serve such purposes is ongoing<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>.</p><p class="" id=d16993e430>Of the multitude of pro-inflammatory mediators synthesized by immune and resident renal cells in LN, interferon (IFN) has been implicated in both systemic and end-organ inflammation<sup><a href="#ref-43">43</a></sup>. Patients with lupus exhibit increased expression of type I IFN response genes<sup><a href="#ref-43">43</a></sup>. The importance of type I IFN in the development of LN stems from experimental and clinical studies that show reduced autoimmunity in type I IFN receptor-deficient lupus-prone mice<sup><a href="#ref-44">44</a></sup>, exacerbation of disease following administration of adenovirus encoding IFN-α to lupus-prone mice<sup><a href="#ref-9">9</a>,<a href="#ref-45">45</a></sup>, and the production of lupus-related antibodies in a significant percentage of patients whose hepatitis C was treated with IFN-α<sup><a href="#ref-46">46</a></sup>. Whether plasmacytoid dendritic cells are the main source of type I IFN remains controversial. In a murine model of anti-GBM nephritis, resident renal cells rather than infiltrating leukocytes were shown to be the dominant source of type I IFN in the kidney which augmented immune-mediated injury<sup><a href="#ref-47">47</a></sup>, possibly through TLR-3 activation<sup><a href="#ref-48">48</a></sup>. Although the investigators did not identify which cells synthesized type I IFN, it is possible that mesangial cells contribute<sup><a href="#ref-49">49</a></sup>. Regulation of type I IFN in mesangial cells is mediated at least in part by microRNA (miR)-130b, and miR-130b expression is decreased in renal specimens from patients and mice with LN<sup><a href="#ref-50">50</a></sup>.</p></div><div class=section><a name=d16993e474 class=n-a></a><h3 class=section-title>(b) Role of infiltrating cells</h3><p class="" id=d16993e479>Both innate and adaptive immune systems play critical roles in systemic and intra-renal inflammatory response in LN. Intra-renal deposition of IgG-containing immune complexes alone is insufficient to initiate pathogenesis and must be accompanied by secretion of pro-inflammatory mediators and recruitment of immune cells. Multiple effector mechanisms have been identified in lupus-prone mice and these include but are not limited to Fc receptors (FcRs), type I IFN receptors, IL-6, and MCP-1<sup><a href="#ref-51">51</a>–<a href="#ref-54">54</a></sup>. Engagement of IgG-containing immune complexes with FcRs is a critical step in the development of LN. Although FcRs are present on mesangial cells, FcR activation on circulating hematopoietic cells rather than resident renal cells initiates pathogenesis in lupus-prone mice<sup><a href="#ref-51">51</a></sup>. Also, the accumulation of apoptotic debris in hematopoietic cells has been reported to promote FcγRI-mediated PI3K signal transduction and disease development in lupus-prone mice, whereas mice deficient in FcγRI were protected<sup><a href="#ref-55">55</a></sup>. Monocytes isolated from patients with LN express increased FcγRI and exhibit increased MCP-1 secretion and chemotactic potential compared with monocytes from healthy subjects<sup><a href="#ref-56">56</a></sup>.</p><p class="" id=d16993e501>Increased serum type I IFN level and induction of IFN-induced gene transcript and protein signature have been observed in peripheral blood mononuclear cells (PBMCs) and renal tissue in patients with LN<sup><a href="#ref-43">43</a></sup>. Serum IFN-α in pediatric patients with lupus can induce monocyte maturation into highly active antigen-presenting dendritic cells<sup><a href="#ref-57">57</a></sup>. These myeloid cells activate naïve T cells and stimulate B-cell expansion and differentiation through B cell-activating factor (BAFF) and exacerbate autoantibody production and autoimmunity. Exogenous viruses have been suggested as a possible trigger of SLE since double-stranded RNA (dsRNA) viruses can induce IFN-α secretion in dendritic cells, but with the possible exception of Epstein-Barr virus, there are limited data to implicate viruses in SLE. Rather, self nucleic acid-containing immune complexes can activate TLRs, which mediate downstream induction of type I IFN synthesis in PBMCs. Expression of long interspersed nuclear element 1, a virus-derived nucleic acid present as a transposable element in the human genome, has recently been reported to induce type I IFN in PBMCs and may contribute to the initiation and amplification of SLE<sup><a href="#ref-58">58</a></sup>. Oxidative stress, mitochondrial dysfunction, and opsonization of apoptotic cells by complement and IgM have also been implicated in increased type I IFN production and NF-κB activation in peripheral blood lymphocytes in patients with SLE<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>. Assessment of IFN-inducible gene expression signature rather than IFN secretion may be a more sensitive method to determine IFN activation in patients with lupus and this is due to blocking antibodies that may be present in serum<sup><a href="#ref-43">43</a></sup>. The roles of IL-6 and MCP-1 in the pathogenesis of LN are well established and have been reviewed elsewhere<sup><a href="#ref-61">61</a>,<a href="#ref-62">62</a></sup>.</p><p class="" id=d16993e535>Chemokine production by infiltrating and resident renal cells mediates the recruitment of monocytes from the circulation and their differentiation into macrophages as they migrate to the site of injury. Macrophages can be divided into two subsets, namely M1 and M2 macrophages<sup><a href="#ref-63">63</a></sup>. M1 macrophages are classic phagocytic, inflammatory macrophages and are activated in response to IFN-γ or TNF-α to secrete large quantities of pro-inflammatory cytokines that include IL-1, IL-6, IL-12, and IL-23. M1 macrophages recruit neutrophils to the site of injury and also induce Th1 and Th17 differentiation<sup><a href="#ref-64">64</a></sup>. M2 macrophages are activated by IL-4 and can be subdivided into three groups comprising M2a macrophages that contribute to the reparative process and secretion of anti-inflammatory cytokines, M2b macrophages that are induced by immune complexes or TLR ligation, and M2c macrophages that possess anti-inflammatory and pro-fibrotic properties and play a key role in the elimination of apoptotic cells<sup><a href="#ref-63">63</a>,<a href="#ref-65">65</a></sup>. Owing to their plasticity and presence of pro- or anti-inflammatory cytokine levels within their microenvironment, macrophages can switch from an M1 to an M2 phenotype<sup><a href="#ref-65">65</a></sup>. Macrophages are key cellular determinants in the pathogenesis of LN and are an important source of key pro-inflammatory cytokines that drive autoimmunity<sup><a href="#ref-66">66</a></sup>. Their detection in renal biopsies from patients with LN is associated with crescent formation and poor renal prognosis<sup><a href="#ref-67">67</a>,<a href="#ref-68">68</a></sup>. It has been reported that M1 macrophages were more abundant in class IV LN compared with class II and V LN and were detected predominately in the glomerulus<sup><a href="#ref-68">68</a></sup>. Macrophages present in tubulo-interstitium belonged to the M2c subgroup, and their number correlated with tubulo-interstitial injury score, anti-dsDNA antibody level, and severity of renal impairment, suggesting a putative role of these cells in tubulo-interstitial injury or fibrosis<sup><a href="#ref-68">68</a></sup>. The clinical relevance of M2c macrophages is also substantiated by elevated plasma levels of sCD163 (released from M2c macrophages) during active SLE<sup><a href="#ref-69">69</a></sup>. Depletion of macrophages using a specific inhibitor to the colony-stimulating factor-1 (CSF-1) receptor in an inducible murine model of LN protected mice from renal inflammation and development of nephritis<sup><a href="#ref-70">70</a></sup>. Lupus-prone mice deficient in MCP-1 exhibited reduced numbers of interstitial macrophages, decreased proteinuria, and improvement in renal histology<sup><a href="#ref-54">54</a></sup>. The role of macrophages in experimental models of LN is dependent on the mouse model used and disease status. In the human setting, CD169<sup>+</sup> inflammatory macrophages are present in the glomeruli of patients with LN, but not healthy subjects, and their number correlated with the severity of proteinuria. Glomerular CD169<sup>+</sup> macrophages decreased in number after corticosteroid treatment<sup><a href="#ref-71">71</a></sup>.</p><p class="" id=d16993e600>B cells are central to LN pathogenesis since they are precursors for autoantibody-producing plasma cells, present antigens to T cells, and contribute to cytokine secretion. Vimentin expressed by infiltrating inflammatory cells has been reported to serve as an autoantigen that induced <i>in situ</i> B-cell selection during tubulo-interstitial inflammation in LN<sup><a href="#ref-72">72</a></sup>. Activated macrophages secrete vimentin in response to pro-inflammatory signaling<sup><a href="#ref-73">73</a></sup> and may be a source of vimentin in the tubulo-interstitium. Alternatively, PTECs undergoing epithelial-to-mesenchymal transition (EMT) and apoptosis may also contribute to the vimentin repertoire in the kidney since vimentin is an intermediate filament synthesized by mesenchymal cells and is also expressed on the cell surface of apoptotic cells<sup><a href="#ref-74">74</a>,<a href="#ref-75">75</a></sup>. Post-translational modification of vimentin may increase its antigenicity and exacerbate autoimmunity<sup><a href="#ref-76">76</a></sup>. Elevated anti-vimentin antibody levels are observed in patients with LN, and the level of these antibodies correlated with tubulo-interstitial inflammation<sup><a href="#ref-72">72</a></sup>. Yet how these autoantibodies contribute to tubulo-interstitial injury remains to be investigated. Anti-vimentin antibodies have also been detected in a proportion of recipients with renal or cardiac allograft, and mycophenolate (MPA) treatment was associated with lower anti-vimentin antibody levels compared with azathioprine in cardiac allograft recipients<sup><a href="#ref-77">77</a>,<a href="#ref-78">78</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d16993e641>Recent knowledge on renal fibrosis in lupus nephritis</h2><p class="" id=d16993e644>Renal fibrosis is a common feature of chronic inflammatory disorders where wound-healing processes persist and become excessive, with prolonged production of growth factors, fibrogenic cytokines and proteolytic enzymes and their inhibitors, leading to increased synthesis and decreased degradation of the extracellular matrix. Both resident renal cells and immune cells contribute to kidney fibrosis.</p><div class=section><a name=d16993e647 class=n-a></a><h3 class=section-title>(a) Role of resident kidney cells</h3><p class="" id=d16993e652>Appropriate regulation of inflammation is essential to prevent progressive kidney fibrosis in LN. Fibronectin is the predominant matrix protein present in glomerulosclerotic lesions and is one of the first matrix components to be deposited during tubulo-interstitial fibrosis<sup><a href="#ref-79">79</a>,<a href="#ref-80">80</a></sup>. Intra-glomerular fibronectin expression is increased in patients and mice with active LN<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup> and co-localizes with IgG deposition, suggesting an association between autoantibody deposition and matrix protein accumulation<sup><a href="#ref-16">16</a></sup>. We reported that anti-dsDNA antibodies can induce both soluble and fibrillar fibronectin synthesis in mesangial cells and PTECs through increased PKC and MAPK signaling and TGF-β1, MCP-1, IL-6, IL-8, and TNF-α secretion<sup><a href="#ref-14">14</a>,<a href="#ref-16">16</a></sup>. Our observation that pro-inflammatory mediators can also contribute to increased fibrogenesis highlights their multi-faceted functions during pathogenesis. The role of TGF-β1 as a key mediator of kidney fibrosis is well established<sup><a href="#ref-81">81</a>,<a href="#ref-82">82</a></sup>, but it is noteworthy that TGF-β1 also plays an important role in immune regulation and can suppress B-cell auto-reactivity during the early phase of disease but can exert pro-fibrotic actions when LN is established<sup><a href="#ref-81">81</a>,<a href="#ref-83">83</a></sup>. Fibrogenic cells are characterized by their ability to synthesize fibrillar collagen. We demonstrated that soluble fibronectin can induce TGF-β1 and collagen synthesis in PTECs, thereby amplifying the fibrogenic response of anti-dsDNA antibodies in the tubulo-interstitium<sup><a href="#ref-14">14</a></sup>. Increased fibronectin has been reported to induce EMT in lung alveolar epithelial cells<sup><a href="#ref-84">84</a></sup>. It is possible that anti-dsDNA antibody induction of fibronectin induces EMT in PTECs, although further studies are warranted to confirm this. In this regard, we have demonstrated that anti-dsDNA antibodies derived from patients with LN during active disease and remission can induce phenotypic changes in PTECs with the acquisition of an elongated, fibroblastic appearance<sup><a href="#ref-10">10</a></sup>. Myofibroblasts are the primary source of matrix proteins in renal fibrosis, and these cells may originate from PTECs undergoing EMT, interstitial fibroblasts, or pericytes<sup><a href="#ref-85">85</a>,<a href="#ref-86">86</a></sup>. There is emerging evidence that epigenetics may contribute to the progression of renal fibrosis, and miR-150 has been implicated in tubulo-interstitial fibrosis in patients with LN through its ability to repress suppressor of cytokine signaling 1<sup><a href="#ref-87">87</a></sup>. In a murine model of chronic kidney disease, reduced fatty acid oxidation in renal tubular epithelial cells appeared to contribute to kidney fibrosis, possibly through mitochondrial dysfunction<sup><a href="#ref-88">88</a></sup>. The role of fatty acid oxidation in tubular epithelial cells and tubulo-interstitial fibrosis in LN is not known.</p></div><div class=section><a name=d16993e724 class=n-a></a><h3 class=section-title>(b) Role of infiltrating cells</h3><p class="" id=d16993e729>Monocyte-derived macrophages play an important role in tissue fibrosis through direct effects on matrix remodeling or indirectly through the activation of myofibroblasts. Unlike pro-inflammatory M1 macrophages, M2 macrophages exert anti-inflammatory responses and contribute to reparative processes following tissue injury. In immune-mediated injury where the inciting factors persist, M2 macrophages drives fibrogenesis through increased synthesis of growth factors, polyamine and proline<sup><a href="#ref-89">89</a></sup> and the generation of a provisional matrix that promotes recruitment and activation of fibroblasts. In animal studies, depletion of macrophages has been shown to reduce the severity of crescentic glomerulonephritis and tubulo-interstitial fibrosis<sup><a href="#ref-90">90</a>–<a href="#ref-92">92</a></sup>. Bone marrow-derived M2 macrophages can undergo myofibroblastic transition and contribute to collagen and α-smooth muscle actin expression in areas of kidney fibrosis in patients with IgA nephropathy or rapidly progressive glomerulonephritis<sup><a href="#ref-93">93</a></sup>. It is possible that M2 macrophages also contribute to kidney fibrosis through a similar mechanism in LN. Although α-smooth muscle actin is often associated with myofibroblasts, there is evidence that it is also expressed in the kidney of healthy subjects and neonatal pericytes and thus is not a reliable marker for myofibroblasts<sup><a href="#ref-94">94</a></sup>. Instead, fibrillar collagen has been suggested to be a more appropriate marker<sup><a href="#ref-94">94</a></sup>. Of note, renal myofibroblasts lacking α-smooth muscle actin expression are associated with increased cell proliferation and collagen production and have been reported to contribute to renal fibrosis<sup><a href="#ref-95">95</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d16993e764>Current and emerging treatments for lupus nephritis and their effects on inflammatory and fibrotic processes</h2><p class="" id=d16993e767>Preservation of nephrons is critical in ensuring long-term renal and patient survival<sup><a href="#ref-1">1</a></sup>. The current standard-of-care induction treatments for severe LN are corticosteroids combined with either cyclophosphamide (CYC) or MPA<sup><a href="#ref-96">96</a>–<a href="#ref-99">99</a></sup>. We have reported that MPA can exert a beneficial role on inflammatory and fibrotic processes induced by anti-dsDNA antibodies in human mesangial cells and PTECs and that this role is independent of its immunosuppressive actions<sup><a href="#ref-14">14</a>–<a href="#ref-16">16</a>,<a href="#ref-39">39</a></sup>. We have also demonstrated that MPA together with methylprednisolone (MP) was more effective than CYC and MP in preserving renal histology with reduced severity of renal fibrosis in New Zealand black and white first-generation (NZB/W F1) mice, possibly through the ability of MPA to decrease PKC-α activation and TGF-β1 expression<sup><a href="#ref-15">15</a></sup>. Long-term follow-up studies have reported a relatively high incidence of chronic kidney failure in patients with LN previously treated with CYC, especially in subjects with a greater propensity for renal fibrosis, such as African-Americans<sup><a href="#ref-100">100</a>–<a href="#ref-102">102</a></sup>. In a murine model of progressive renal interstitial fibrosis, CYC treatment alone was shown to induce interstitial fibrosis, which was associated with the depletion of macrophages, although the subtype was not determined<sup><a href="#ref-103">103</a></sup>. Whether exposure to CYC in susceptible individuals tips the balance in favor of fibrosis instead of repair is an intriguing possibility with significant clinical implications. In patients with neoplastic diseases, CYC treatment was associated with urinary bladder inflammation and fibrosis, and the severity of fibrosis was associated with the dose and duration of CYC treatment<sup><a href="#ref-104">104</a></sup>. It was unclear whether the bladder fibrosis was consequent solely to CYC-induced uroepithelial inflammation or was aggravated by a separate pro-fibrotic effect of CYC. In addition to MMF and CYC, azathioprine and calcineurin inhibitors are used in the treatment of lupus. Whether these pharmacologic agents, in addition to their immunosuppressive actions, can exert a direct effect on kidney inflammation has not been investigated. In contrast, the chronic nephrotoxicity of calcineurin inhibitors has been investigated in organ transplant recipients and is characterized by renal parenchymal fibrosis, vascular hyalinization and prominent induction of TGF-β<sup><a href="#ref-105">105</a></sup>. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers have been shown to reduce proteinuria and the rate of renal function deterioration in patients with chronic glomerular diseases such as diabetic nephropathy or IgA nephropathy. In patients with quiescent LN and persistent proteinuria, treatment with ACE inhibitors or angiotensin II receptor blockers resulted in sustained improvements in proteinuria and serum albumin level<sup><a href="#ref-106">106</a></sup>. Treatment of lupus-prone mice with ACE inhibitors delayed the onset of proteinuria, reduced disease progression and chronic kidney lesions, and was associated with decreased intra-glomerular expression of TGF-β1 and TGF-β2 and splenic production of type 2 cytokines such as IL-4 and IL-10<sup><a href="#ref-107">107</a></sup>. It is conceivable that treatment of lupus patients who have chronic renal damage with blockade of the renin-angiotensin pathway should exert a similar beneficial effect on kidney fibrosis.</p><p class="" id=d16993e823>Although high-dose corticosteroids remain a cornerstone in the treatment of severe active LN, the use of pulse corticosteroids is highly variable between clinicians<sup><a href="#ref-96">96</a>–<a href="#ref-99">99</a></sup>. Intravenous pulse corticosteroid treatment has been reported to be more effective than oral corticosteroids in suppressing circulating and intra-renal expression of pro-inflammatory cytokines in autoimmune conditions, including LN<sup><a href="#ref-108">108</a>–<a href="#ref-110">110</a></sup>. Although this should theoretically be accompanied by reduction of renal inflammation, the impact of pulse corticosteroids on renal inflammation and fibrosis remains to be examined.</p><p class="" id=d16993e840>Biological therapies target key molecules in pathogenic pathways, based on knowledge of the immunopathogenic mechanisms in LN. Biologics tested or being developed in SLE or LN (or both) inhibit B-cell proliferation and activation (for example, anti-BAFF), target B-cell subpopulations (for example, anti-CD20), reduce co-stimulatory signal in T lymphocyte activation (for example, cytotoxic T-lymphocyte associated protein 4 (CTLA-4) Ig), or antagonize the effect of key cytokines (for example, IFN-α)<sup><a href="#ref-111">111</a>–<a href="#ref-115">115</a></sup>. Treatment of lupus-prone mice with anti-BAFF or CTLA-4 Ig was shown to ameliorate glomerular inflammation and tubular damage and decrease intra-renal inflammatory cytokine expression<sup><a href="#ref-116">116</a>,<a href="#ref-117">117</a></sup>. Anti-IL-6 monoclonal antibodies were shown to ameliorate nephritis in murine LN models<sup><a href="#ref-118">118</a>,<a href="#ref-119">119</a></sup>; yet in a controlled trial, the anti-IL-6 antibody sirukumab given for 24 weeks did not reduce proteinuria that persisted despite standard induction immunosuppressive treatment for LN, and the treatment was associated with excessive serious infections<sup><a href="#ref-120">120</a></sup>. TWEAK (TNF-like weak inducer of apoptosis) is a member of the TNF family of cytokines, and the Fn14 gene codes for the TWEAK receptor. Monocytes, dendritic cells, and natural killer cells are the major sources of TWEAK. Although transient activation of the TWEAK/Fn14 pathway is involved in tissue repair after injury, excessive or persistent activation of the pathway is implicated in autoimmune diseases, including lupus, and activation of the pathway in diseased organs has been reported to drive local inflammation leading to fibrosis<sup><a href="#ref-121">121</a></sup>. Anti-TWEAK antibody therapy has yielded promising results in animal models of autoimmune diseases<sup><a href="#ref-122">122</a>,<a href="#ref-123">123</a></sup>. A phase II randomized placebo-controlled clinical trial that explored the efficacy, tolerability, and safety of anti-TWEAK antibody as an add-on therapy in patients with class III/IV LN did not demonstrate sufficient efficacy, and the drug development program was terminated (ATLAS study, NCT01499355).</p><p class="" id=d16993e880>Apart from positive trial outcomes with belimumab and anifrolumab in lupus patients without severe nephritis<sup><a href="#ref-111">111</a>,<a href="#ref-112">112</a>,<a href="#ref-124">124</a></sup>, the other clinical trials on biologics to date either failed to achieve the efficacy study endpoints or have been aborted because of perceived unfavorable balance in effect size versus adverse events<sup><a href="#ref-114">114</a>,<a href="#ref-115">115</a>,<a href="#ref-125">125</a></sup>. The data nevertheless suggest that a subset of patients could derive clinically observable benefit when these agents were added to conventional immunosuppressive therapies for active LN<sup><a href="#ref-113">113</a>–<a href="#ref-115">115</a></sup>. Factors contributing to the apparent discrepancy between biological effect and clinical outcomes include efficacy of background therapy, definition of clinical study outcomes<sup><a href="#ref-126">126</a></sup>, and patient heterogeneity, the last of which was evidenced by the greater impact of rituximab treatment in African-Americans compared with Caucasians<sup><a href="#ref-114">114</a></sup>. The impact of these agents on renal parenchymal inflammation or fibrosis remains unknown as this is rarely an outcome parameter and the data have not been systematically examined.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d16993e922>Conclusions</h2><p class="" id=d16993e925>Inflammation and fibrosis are key processes in LN and involve the interplay of immune cells of the innate and adaptive immune system and resident renal cells. The identification of molecules or pathways that contribute to the development of LN has flourished over the past decade and is ever-expanding. Identifying the roles of inflammatory mediators and the molecular mechanism that regulate inflammatory responses is made more challenging by their multi-faceted roles, not only at the onset of pathogenesis but also during the effector phase where they facilitate kidney injury. Defining how these molecules contribute to disease pathogenesis is crucial before more focused therapeutic strategies can be devised. Despite a sound mechanistic rationale and encouraging animal data, the clinical results with biologics have been disappointing to date, yet the failure to demonstrate clinical utility could reflect deficiencies in protocol design rather than a lack of biological effect. There are a number of murine models of LN, and choosing an optimal model is imperative to identify key checkpoints of kidney injury and in the evaluation of potential therapeutic interventions. <a href="#T1">Table 1</a> summarizes the phenotypic differences between different murine models of LN. Current therapies primarily target immunological and inflammatory pathways, yet disease mechanisms that lead to myofibroblast conversion and fibrotic processes should not be overlooked. Lastly, given that a multitude of effector mechanisms are activated in patients with LN, biological profiling of patients with a proteomics or genomics approach (or both) may facilitate better selection of treatment regimens.</p><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. Phenotypic differences between different murine models of lupus nephritis.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d16993e942 class=n-a></a><thead><a name=d16993e944 class=n-a></a><tr><a name=d16993e946 class=n-a></a><th align=left colspan=1 rowspan=1><a name=d16993e948 class=n-a></a></th><th align=left colspan=1 rowspan=1 valign=top><a name=d16993e950 class=n-a></a>Strain/<br class=br>model</th><th align=left colspan=1 rowspan=1 valign=top><a name=d16993e955 class=n-a></a>Clinical manifestations</th><th align=left colspan=1 rowspan=1 valign=top><a name=d16993e958 class=n-a></a>Anti-dsDNA antibody<br class=br>production</th><th align=left colspan=1 rowspan=1 valign=top><a name=d16993e963 class=n-a></a>Renal histological changes</th><th align=left colspan=1 rowspan=1 valign=top><a name=d16993e967 class=n-a></a>References</th></tr></thead><tbody><a name=d16993e972 class=n-a></a><tr><a name=d16993e974 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e976 class=n-a></a>Spontaneous<br class=br>lupus nephritis<br class=br>models</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e983 class=n-a></a>NZB/W F1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e986 class=n-a></a>• Disease is more severe and occurs<br class=br>earlier in female mice.<br class=br>• 50% mortality at 8 months in female<br class=br>mice and at 15 months in male mice<br class=br>• Proteinuria appears at 5 months.<br class=br>• Death due to immune-mediated GN</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e999 class=n-a></a>High titres of IgG<br class=br>anti-dsDNA antibodies<br class=br>detected by 4–5 months<br class=br>of age</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1008 class=n-a></a>• Deposition of IgG and C3 in glomerular and tubular<br class=br>basement membranes<br class=br>• Proliferative changes in mesangial and endothelial cells<br class=br>• Thickening of glomerular basement membrane<br class=br>• Increased glomerular and tubulo-interstitial<br class=br>expression of PKC-α, PKC-βI, PKC-βII, TGF-β1,<br class=br>collagen, and fibronectin<br class=br>• Glomerulosclerosis<br class=br>• Mononuclear cell infiltration into interstitium<br class=br>• Increased cytokine and chemokine expression<br class=br>• Increased tubulo-interstitial activation of MAPK<br class=br>signaling pathway<br class=br>• Tubulo-interstitial fibrosis<br class=br>• Tubular atrophy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1040 class=n-a></a><a href="#ref-15">15</a>,<a href="#ref-16">16</a>,<a href="#ref-39">39</a>,<a href="#ref-127">127</a>–<a href="#ref-129">129</a></td></tr><tr><a name=d16993e1057 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d16993e1059 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1061 class=n-a></a>NZM2328</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1064 class=n-a></a>• Disease is more severe in female<br class=br>mice.</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1069 class=n-a></a>High titres of IgG anti-<br class=br>dsDNA antibodies</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1074 class=n-a></a>• Glomerulosclerosis<br class=br>• Tubular atrophy<br class=br>• Congenic NZM.C57Lc1 mice develop severe chronic<br class=br>GN without antinuclear antibody production</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1084 class=n-a></a><a href="#ref-127">127</a>,<a href="#ref-130">130</a></td></tr><tr><a name=d16993e1092 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d16993e1094 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1096 class=n-a></a>NZM2410</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1099 class=n-a></a>• Disease manifestations similar to<br class=br>NZB/W F1 mice<br class=br>• Disease severity similar in female<br class=br>and male mice</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1108 class=n-a></a>High titres of IgG anti-<br class=br>dsDNA antibodies</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1113 class=n-a></a>• Early onset of glomerulosclerosis compared with<br class=br>NZB/W F1 and MRL/lpr mice<br class=br>• Deposition of IgG and C3 in glomerular and tubular<br class=br>basement membranes<br class=br>• Proliferative changes in mesangial and endothelial<br class=br>cells<br class=br>• Thickening of glomerular basement membrane<br class=br>• Glomerulosclerosis<br class=br>• Tubulo-interstitial fibrosis<br class=br>• Tubular atrophy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1136 class=n-a></a><a href="#ref-127">127</a></td></tr><tr><a name=d16993e1141 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d16993e1143 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1145 class=n-a></a>MRL/lpr</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1148 class=n-a></a>• Marked lymphadenopathy and<br class=br>splenomegaly<br class=br>• 50% mortality at 6 months in female<br class=br>and male mice<br class=br>• Proteinuria appears at 1–3 months in<br class=br>female mice.<br class=br> • Death due to immune-mediated GN</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1164 class=n-a></a>High titres of IgG<br class=br>anti-dsDNA antibodies<br class=br>detected at 6–8 weeks<br class=br>of age</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1173 class=n-a></a>• Deposition of IgG and C3 in glomerular and tubular basement membranes<br class=br>• Subacute proliferative changes in mesangial and<br class=br>endothelial<br class=br>cells<br class=br>• Thickening of glomerular basement membrane<br class=br>• Crescent formation<br class=br>• Mononuclear cell infiltration into interstitium<br class=br>• Increased cytokine and chemokine expression<br class=br>• Increased collagen accumulation in glomerular and<br class=br>tubular basement membranes</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1196 class=n-a></a><a href="#ref-127">127</a>–<a href="#ref-129">129</a>,<a href="#ref-131">131</a></td></tr><tr><a name=d16993e1207 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d16993e1209 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1211 class=n-a></a>BXSB</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1214 class=n-a></a>• Disease predominance in male mice<br class=br>• Late onset of lupus in female mice<br class=br>• 50% mortality at 5 months in male<br class=br>mice and at 15 months in female mice<br class=br>• Proteinuria appears by 3 months.<br class=br>• Death due to immune-mediated GN</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1227 class=n-a></a>High titres of IgG anti-<br class=br>dsDNA antibodies</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1232 class=n-a></a>• Deposition of IgG and C3 in glomerular and tubular<br class=br>basement membranes<br class=br>• Acute to subacute GN<br class=br>• Exudation of neutrophils into the glomerulus<br class=br>• Subacute proliferative changes in mesangial and<br class=br>endothelial cells<br class=br>• Thickening of glomerular basement membrane<br class=br>• Development of proliferative nephritis</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1251 class=n-a></a><a href="#ref-127">127</a>–<a href="#ref-129">129</a>,<a href="#ref-132">132</a></td></tr><tr><a name=d16993e1263 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1265 class=n-a></a>Induction of<br class=br>lupus nephritis in<br class=br>non-autoimmune<br class=br>mice</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1274 class=n-a></a>Pristane</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1277 class=n-a></a>• Female mice more susceptible to<br class=br>disease<br class=br>• Nephritis occurs 6 months<br class=br>after pristane-injection, although<br class=br>development of nephritis is variable.<br class=br>• Moderate proteinuria</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1290 class=n-a></a>IgM and not IgG anti<br class=br>-ssDNA antibodies<br class=br>detected within<br class=br>1–4 weeks of pristane<br class=br>injection</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1301 class=n-a></a>• Development of renal disease more severe in BALB/c<br class=br>mice than in C57BL/6 mice<br class=br>• Focal to global proliferative lesions<br class=br>• Effacement of capillaries<br class=br>• Glomerular basement membrane thickening<br class=br>• Deposition of IgG, IgM, and C3 in mesangial and<br class=br>subendothelial area<br class=br>• Immune complexes in these mice are not attributed<br class=br>to IgG anti-dsDNA antibodies.</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1322 class=n-a></a><a href="#ref-133">133</a>–<a href="#ref-136">136</a></td></tr><tr><a name=d16993e1330 class=n-a></a><td align=left colspan=1 rowspan=1><a name=d16993e1332 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1334 class=n-a></a>Chronic<br class=br>graft-<br class=br>versus-host<br class=br>disease</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1343 class=n-a></a>• 50% mortality between 9 and 16<br class=br>weeks post-induction<br class=br>• Moderate proteinuria observed<br class=br>2 weeks post-induction with slow<br class=br>increase up to 6 weeks</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1354 class=n-a></a>IgG anti-dsDNA<br class=br>antibodies detected</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1359 class=n-a></a>• Immune complexes detected in glomeruli 4–5 weeks<br class=br>post-induction<br class=br>• C57BL/6 mice develop mild nephritis with antibody<br class=br>deposition in mesangial cell (class II).<br class=br>• BALB/c and SJL mice develop proliferative lupus<br class=br>nephritis with IgG deposition present along the<br class=br>capillary loops.<br class=br>• Membranous nephritis<br class=br>• Electron-dense deposits in the mesangium,<br class=br>subendothelial, and subepithelial regions<br class=br>• Induction of pro-inflammatory cytokines through<br class=br>upregulation of TWEAK</td><td align=left colspan=1 rowspan=1 valign=top><a name=d16993e1386 class=n-a></a><a href="#ref-127">127</a>,<a href="#ref-135">135</a>,<a href="#ref-137">137</a>,<a href="#ref-138">138</a></td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d16993e1404 class=n-a></a><p id=d16993e1405> C3, complement 3; dsDNA, double-stranded DNA; GN, glomerulonephritis; Ig, immunoglobulin; MAPK, mitogen-activated protein kinase; NZB/W F1, New Zealand black and white first generation; PKC, protein kinase C; ssDNA, single-stranded DNA; TGF-β1, transforming growth factor-beta 1; TWEAK, tumor necrosis factor-like weak inducer of apoptosis.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d16993e1413>Abbreviations</h2><p class="" id=d16993e1416>ACE, angiotensin-converting enzyme; BAFF, B cell-activating factor; CTLA-4, cytotoxic T-lymphocyte associated protein 4; CYC, cyclophosphamide; dsDNA, double-stranded DNA; EMT, epithelial-to-mesenchymal transition; FcR, Fc receptor; GBM, glomerular basement membrane; IFN, interferon; Ig, immunoglobulin; IL, interleukin; LN, lupus nephritis; MAPK, mitogen-activated protein kinase; MCP-1, monocyte chemoattractant protein-1; miR, microRNA; MP, methylprednisolone; MPA, mycophenolate; NF-κB, nuclear factor kappa B; PBMC, peripheral blood mononuclear cell; PI3K, phosphoinositide 3-kinase; PKC, protein kinase C; PTEC, proximal tubular epithelial cell; SLE, systemic lupus erythematosus; TGF-β1, transforming growth factor-beta 1; TLR, Toll-like receptor; TNF-α, tumor necrosis factor-alpha; TWEAK, TNF-like weak inducer of apoptosis.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d16993e1 class=n-a></a><h2 class=main-title id=d17384>Competing interests</h2><p class=metadata-entry><a name=d16993e105 class=n-a></a><p id=d16993e106> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d16993e1 class=n-a></a><h2 class=main-title id=d17386>Grant information</h2><p>Studies undertaken by TMC’s group [1, 4, 10, 12, 14–17, 22, 31, 39] were funded by the RGC General Research Fund (HKU 7366/04M, 7550/06M, 7604/10M, HKU 7607/12M, 17100914, and 17126814) and UGC Matching Grant Schemes (Phases IV, V, and VI). SY is supported by the Wai Hung Charitable Foundation Limited and the ‘Yu Chiu Kwong Professorship in Medicine’ Endowment Fund awarded to TMC.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d16993e1423 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d17850>References</h2><div class="section ref-list"><a name=d16993e1423 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d16993e1430 class=n-a></a>Yap DY, Tang CS, Ma MK, <i> et al.</i>: Survival analysis and causes of mortality in patients with lupus nephritis. <i>Nephrol Dial Transplant.</i> 2012; <b>27</b>(8): 3248–54. <a target=xrefwindow id=d16993e1441 href="http://www.ncbi.nlm.nih.gov/pubmed/22523116">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1444 href="http://dx.doi.org/10.1093/ndt/gfs073">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1040322"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e1453 class=n-a></a>Bernatsky S, Boivin JF, Joseph L, <i> et al.</i>: Mortality in systemic lupus erythematosus. <i>Arthritis Rheum.</i> 2006; <b>54</b>(8): 2550–7. <a target=xrefwindow id=d16993e1464 href="http://www.ncbi.nlm.nih.gov/pubmed/16868977">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1467 href="http://dx.doi.org/10.1002/art.21955">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1040322">F1000 Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d16993e1480 class=n-a></a>Saxena R, Mahajan T, Mohan C: Lupus nephritis: current update. <i>Arthritis Res Ther.</i> 2011; <b>13</b>(5): 240. <a target=xrefwindow id=d16993e1488 href="http://www.ncbi.nlm.nih.gov/pubmed/22078716">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1491 href="http://dx.doi.org/10.1186/ar3378">Publisher Full Text </a> | <a target=xrefwindow id=d16993e1494 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3308062">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d16993e1503 class=n-a></a>Chan TM: Treatment of severe lupus nephritis: the new horizon. <i>Nat Rev Nephrol.</i> 2015; <b>11</b>(1): 46–61. <a target=xrefwindow id=d16993e1511 href="http://www.ncbi.nlm.nih.gov/pubmed/25421826">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1514 href="http://dx.doi.org/10.1038/nrneph.2014.215">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726106143"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e1523 class=n-a></a>Tektonidou MG, Dasgupta A, Ward MM: Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971–2015: A Systematic Review and Bayesian Meta-Analysis. <i>Arthritis Rheumatol.</i> 2016; <b>68</b>(6): 1432–41. <a target=xrefwindow id=d16993e1531 href="http://www.ncbi.nlm.nih.gov/pubmed/26815601">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1534 href="http://dx.doi.org/10.1002/art.39594">Publisher Full Text </a> | <a target=xrefwindow id=d16993e1537 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5071782">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726106143">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d16993e1551 class=n-a></a>Weening JJ, D'Agati VD, Schwartz MM, <i> et al.</i>: The classification of glomerulonephritis in systemic lupus erythematosus revisited. <i>J Am Soc Nephrol.</i> 2004; <b>15</b>(2): 241–50. <a target=xrefwindow id=d16993e1562 href="http://www.ncbi.nlm.nih.gov/pubmed/14747370">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1565 href="http://dx.doi.org/10.1097/01.ASN.0000108969.21691.5D">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725779723"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e1574 class=n-a></a>Dieker J, Tel J, Pieterse E, <i> et al.</i>: Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis. <i>Arthritis Rheumatol.</i> 2016; <b>68</b>(2): 462–72. <a target=xrefwindow id=d16993e1585 href="http://www.ncbi.nlm.nih.gov/pubmed/26360137">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1588 href="http://dx.doi.org/10.1002/art.39417">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725779723">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d16993e1601 class=n-a></a>Davidson A, Berthier CC, Kretzler M: Pathogenetic mechanisms in lupus nephritis. In: Wallace DJ, Hahn BH, eds. <i>Dubois' lupus erythematosus and related syndromes</i>. Philadelphia: Elsevier, 2013; 237–55. <a target=xrefwindow id=d16993e1606 href="http://dx.doi.org/10.1016/B978-1-4377-1893-5.00018-2">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d16993e1615 class=n-a></a>Triantafyllopoulou A, Franzke CW, Seshan SV, <i> et al.</i>: Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. <i>Proc Natl Acad Sci U S A.</i> 2010; <b>107</b>(7): 3012–7. <a target=xrefwindow id=d16993e1626 href="http://www.ncbi.nlm.nih.gov/pubmed/20133703">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1629 href="http://dx.doi.org/10.1073/pnas.0914902107">Publisher Full Text </a> | <a target=xrefwindow id=d16993e1633 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2840310">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d16993e1642 class=n-a></a>Yung S, Tsang RC, Sun Y, <i> et al.</i>: Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: implications on tubulointerstitial inflammation in lupus nephritis. <i>J Am Soc Nephrol.</i> 2005; <b>16</b>(11): 3281–94. <a target=xrefwindow id=d16993e1653 href="http://www.ncbi.nlm.nih.gov/pubmed/16192422">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1656 href="http://dx.doi.org/10.1681/ASN.2004110917">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/9327956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e1665 class=n-a></a>Chang A, Henderson SG, Brandt D, <i> et al.</i>: <i>In situ</i> B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. <i>J Immunol.</i> 2011; <b>186</b>(3): 1849–60. <a target=xrefwindow id=d16993e1679 href="http://www.ncbi.nlm.nih.gov/pubmed/21187439">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1683 href="http://dx.doi.org/10.4049/jimmunol.1001983">Publisher Full Text </a> | <a target=xrefwindow id=d16993e1686 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3124090">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/9327956">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d16993e1700 class=n-a></a>Chan TM, Leung JK, Ho SK, <i> et al.</i>: Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus. <i>J Am Soc Nephrol.</i> 2002; <b>13</b>(5): 1219–29. <a target=xrefwindow id=d16993e1711 href="http://www.ncbi.nlm.nih.gov/pubmed/11961009">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1714 href="http://dx.doi.org/10.1097/01.ASN.0000014223.71109.13">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d16993e1723 class=n-a></a>Isenberg DA, Manson JJ, Ehrenstein MR, <i> et al.</i>: Fifty years of anti-ds DNA antibodies: are we approaching journey's end? <i>Rheumatology (Oxford).</i> 2007; <b>46</b>(7): 1052–6. <a target=xrefwindow id=d16993e1734 href="http://www.ncbi.nlm.nih.gov/pubmed/17500073">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1737 href="http://dx.doi.org/10.1093/rheumatology/kem112">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d16993e1746 class=n-a></a>Yung S, Ng CY, Ho SK, <i> et al.</i>: Anti-dsDNA antibody induces soluble fibronectin secretion by proximal renal tubular epithelial cells and downstream increase of TGF-β1 and collagen synthesis. <i>J Autoimmun.</i> 2015; <b>58</b>: 111–22. <a target=xrefwindow id=d16993e1757 href="http://www.ncbi.nlm.nih.gov/pubmed/25666976">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1760 href="http://dx.doi.org/10.1016/j.jaut.2015.01.008">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d16993e1769 class=n-a></a>Yung S, Zhang Q, Chau MK, <i> et al.</i>: Distinct effects of mycophenolate mofetil and cyclophosphamide on renal fibrosis in NZBWF1/J mice. <i>Autoimmunity.</i> 2015; <b>48</b>(7): 471–87. <a target=xrefwindow id=d16993e1780 href="http://www.ncbi.nlm.nih.gov/pubmed/26099989">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1783 href="http://dx.doi.org/10.3109/08916934.2015.1054027">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d16993e1792 class=n-a></a>Yung S, Zhang Q, Zhang CZ, <i> et al.</i>: Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid. <i>Arthritis Rheum.</i> 2009; <b>60</b>(7): 2071–82. <a target=xrefwindow id=d16993e1803 href="http://www.ncbi.nlm.nih.gov/pubmed/19565476">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1806 href="http://dx.doi.org/10.1002/art.24573">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d16993e1815 class=n-a></a>Yung S, Tsang RC, Leung JK, <i> et al.</i>: Increased mesangial cell hyaluronan expression in lupus nephritis is mediated by anti-DNA antibody-induced IL-1beta. <i>Kidney Int.</i> 2006; <b>69</b>(2): 272–80. <a target=xrefwindow id=d16993e1826 href="http://www.ncbi.nlm.nih.gov/pubmed/16408116">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1829 href="http://dx.doi.org/10.1038/sj.ki.5000042">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d16993e1839 class=n-a></a>Chan TM, Yu PM, Tsang KL, <i> et al.</i>: Endothelial cell binding by human polyclonal anti-DNA antibodies: relationship to disease activity and endothelial functional alterations. <i>Clin Exp Immunol.</i> 1995; <b>100</b>(3): 506–13. <a target=xrefwindow id=d16993e1850 href="http://www.ncbi.nlm.nih.gov/pubmed/7774063">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1853 href="http://dx.doi.org/10.1111/j.1365-2249.1995.tb03730.x">Publisher Full Text </a> | <a target=xrefwindow id=d16993e1857 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1534478">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d16993e1866 class=n-a></a>Neng Lai K, Leung JC, Bik Lai K, <i> et al.</i>: Anti-DNA autoantibodies stimulate the release of interleukin-1 and interleukin-6 from endothelial cells. <i>J Pathol.</i> 1996; <b>178</b>(4): 451–7. <a target=xrefwindow id=d16993e1877 href="http://www.ncbi.nlm.nih.gov/pubmed/8691326">PubMed Abstract </a> | <a target="xrefwindow" id="d16993e1880" href="http://dx.doi.org/10.1002/(SICI)1096-9896(199604)178:4<451::AID-PATH499&gt;3.0.CO;2-P">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d16993e1889 class=n-a></a>Zhang H, Zhao C, Wang S, <i> et al.</i>: Anti-dsDNA antibodies induce inflammation via endoplasmic reticulum stress in human mesangial cells. <i>J Transl Med.</i> 2015; <b>13</b>: 178. <a target=xrefwindow id=d16993e1900 href="http://www.ncbi.nlm.nih.gov/pubmed/26040555">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1903 href="http://dx.doi.org/10.1186/s12967-015-0536-7">Publisher Full Text </a> | <a target=xrefwindow id=d16993e1907 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4467615">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d16993e1916 class=n-a></a>Madaio MP, Hodder S, Schwartz RS, <i> et al.</i>: Responsiveness of autoimmune and normal mice to nucleic acid antigens. <i>J Immunol.</i> 1984; <b>132</b>(2): 872–6. <a target=xrefwindow id=d16993e1927 href="http://www.ncbi.nlm.nih.gov/pubmed/6690621">PubMed Abstract </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5818957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e1936 class=n-a></a>Yung S, Cheung KF, Zhang Q, <i> et al.</i>: Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis. <i>J Am Soc Nephrol.</i> 2010; <b>21</b>(11): 1912–27. <a target=xrefwindow id=d16993e1947 href="http://www.ncbi.nlm.nih.gov/pubmed/20847146">PubMed Abstract </a> | <a target=xrefwindow id=d16993e1950 href="http://dx.doi.org/10.1681/ASN.2009080805">Publisher Full Text </a> | <a target=xrefwindow id=d16993e1954 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3014006">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5818957">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d16993e1967 class=n-a></a>Mostoslavsky G, Fischel R, Yachimovich N, <i> et al.</i>: Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. <i>Eur J Immunol.</i> 2001; <b>31</b>(4): 1221–7. <a target=xrefwindow id=d16993e1978 href="http://www.ncbi.nlm.nih.gov/pubmed/11298348">PubMed Abstract </a> | <a target="xrefwindow" id="d16993e1981" href="http://dx.doi.org/10.1002/1521-4141(200104)31:4<1221::AID-IMMU1221&gt;3.0.CO;2-P">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d16993e1991 class=n-a></a>Deocharan B, Qing X, Beger E, <i> et al.</i>: Antigenic triggers and molecular targets for anti-double-stranded DNA antibodies. <i>Lupus.</i> 2002; <b>11</b>(12): 865–71. <a target=xrefwindow id=d16993e2002 href="http://www.ncbi.nlm.nih.gov/pubmed/12529052">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2005 href="http://dx.doi.org/10.1191/0961203302lu308rr">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726327347"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e2014 class=n-a></a>Olin AI, Mörgelin M, Truedsson L, <i> et al.</i>: Pathogenic mechanisms in lupus nephritis: Nucleosomes bind aberrant laminin β1 with high affinity and colocalize in the electron-dense deposits. <i>Arthritis rheumatol.</i> 2014; <b>66</b>(2): 397–406. <a target=xrefwindow id=d16993e2025 href="http://www.ncbi.nlm.nih.gov/pubmed/24504812">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2028 href="http://dx.doi.org/10.1002/art.38250">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726327347">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d16993e2041 class=n-a></a>Waters ST, McDuffie M, Bagavant H, <i> et al.</i>: Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. <i>J Exp Med.</i> 2004; <b>199</b>(2): 255–64. <a target=xrefwindow id=d16993e2052 href="http://www.ncbi.nlm.nih.gov/pubmed/14718514">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2055 href="http://dx.doi.org/10.1084/jem.20031519">Publisher Full Text </a> | <a target=xrefwindow id=d16993e2059 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2211766">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d16993e2068 class=n-a></a>Jacob CO, Zang S, Li L, <i> et al.</i>: Pivotal role of Stat4 and Stat6 in the pathogenesis of the lupus-like disease in the New Zealand mixed 2328 mice. <i>J Immunol.</i> 2003; <b>171</b>(3): 1564–71. <a target=xrefwindow id=d16993e2079 href="http://www.ncbi.nlm.nih.gov/pubmed/12874250">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2082 href="http://dx.doi.org/10.4049/jimmunol.171.3.1564">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d16993e2091 class=n-a></a>Alba P, Bento L, Cuadrado MJ, <i> et al.</i>: Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. <i>Ann Rheum Dis.</i> 2003; <b>62</b>(6): 556–60. <a target=xrefwindow id=d16993e2102 href="http://www.ncbi.nlm.nih.gov/pubmed/12759294">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2105 href="http://dx.doi.org/10.1136/ard.62.6.556">Publisher Full Text </a> | <a target=xrefwindow id=d16993e2109 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1754557">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d16993e2118 class=n-a></a>Yung S, Chan TM: Anti-dsDNA antibodies and resident renal cells - Their putative roles in pathogenesis of renal lesions in lupus nephritis. <i>Clin Immunol.</i> 2016; pii: S1521-6616(16)30361-8. <a target=xrefwindow id=d16993e2123 href="http://www.ncbi.nlm.nih.gov/pubmed/27612436">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2126 href="http://dx.doi.org/10.1016/j.clim.2016.09.002">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d16993e2136 class=n-a></a>Deocharan B, Qing X, Lichauco J, <i> et al.</i>: Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. <i>J Immunol.</i> 2002; <b>168</b>(6): 3072–8. <a target=xrefwindow id=d16993e2147 href="http://www.ncbi.nlm.nih.gov/pubmed/11884481">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2150 href="http://dx.doi.org/10.4049/jimmunol.168.6.3072">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d16993e2159 class=n-a></a>Cheung KF, Yung S, Chau MK, <i> et al.</i>: Annexin II-binding immunoglobulins in patients with lupus nephritis and their correlation with disease manifestations. <i>Clin Sci (Lond).</i> 2017; <b>131</b>(8): 653–71. <a target=xrefwindow id=d16993e2170 href="http://www.ncbi.nlm.nih.gov/pubmed/28183811">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2173 href="http://dx.doi.org/10.1042/CS20160732">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d16993e2182 class=n-a></a>Qing X, Zavadil J, Crosby MB, <i> et al.</i>: Nephritogenic anti-DNA antibodies regulate gene expression in MRL/<i>lpr</i> mouse glomerular mesangial cells. <i>Arthritis Rheum.</i> 2006; <b>54</b>(7): 2198–210. <a target=xrefwindow id=d16993e2196 href="http://www.ncbi.nlm.nih.gov/pubmed/16804897">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2200 href="http://dx.doi.org/10.1002/art.21934">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d16993e2209 class=n-a></a>Qing X, Pitashny M, Thomas DB, <i> et al.</i>: Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury. <i>Immunol Lett.</i> 2008; <b>121</b>(1): 61–73. <a target=xrefwindow id=d16993e2220 href="http://www.ncbi.nlm.nih.gov/pubmed/18822317">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2223 href="http://dx.doi.org/10.1016/j.imlet.2008.08.007">Publisher Full Text </a> | <a target=xrefwindow id=d16993e2227 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2677706">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d16993e2236 class=n-a></a>Im SR, Im SW, Chung HY, <i> et al.</i>: Cell- and nuclear-penetrating anti-dsDNA autoantibodies have multiple arginines in CDR3 of VH and increase cellular level of pERK and Bcl-2 in mesangial cells. <i>Mol Immunol.</i> 2015; <b>67</b>(2 Pt B): 377–87. <a target=xrefwindow id=d16993e2247 href="http://www.ncbi.nlm.nih.gov/pubmed/26189065">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2250 href="http://dx.doi.org/10.1016/j.molimm.2015.06.025">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d16993e2259 class=n-a></a>Rovin BH, Tan LC: Role of protein kinase pathways in IL-1-induced chemoattractant expression by human mesangial cells. <i>Kidney Int.</i> 1994; <b>46</b>(4): 1059–68. <a target=xrefwindow id=d16993e2267 href="http://www.ncbi.nlm.nih.gov/pubmed/7861699">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2270 href="http://dx.doi.org/10.1038/ki.1994.367">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d16993e2280 class=n-a></a>McCarthy EM, Smith S, Lee RZ, <i> et al.</i>: The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients. <i>Rheumatology (Oxford).</i> 2014; <b>53</b>(9): 1586–94. <a target=xrefwindow id=d16993e2291 href="http://www.ncbi.nlm.nih.gov/pubmed/24706988">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2294 href="http://dx.doi.org/10.1093/rheumatology/ket428">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d16993e2303 class=n-a></a>Hansen C, Otto E, Kuhlemann K, <i> et al.</i>: Glycosaminoglycans in autoimmunity. <i>Clin Exp Rheumatol.</i> 1996; <b>14</b>(Suppl 15): S59–67. <a target=xrefwindow id=d16993e2314 href="http://www.ncbi.nlm.nih.gov/pubmed/8828950">PubMed Abstract </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d16993e2323 class=n-a></a>Pitashny M, Schwartz N, Qing X, <i> et al.</i>: Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis. <i>Arthritis Rheum.</i> 2007; <b>56</b>(6): 1894–903. <a target=xrefwindow id=d16993e2334 href="http://www.ncbi.nlm.nih.gov/pubmed/17530720">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2337 href="http://dx.doi.org/10.1002/art.22594">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d16993e2346 class=n-a></a>Yung S, Ng CY, Au KY, <i> et al.</i>: Binding of anti-dsDNA antibodies to proximal tubular epithelial cells contributes to renal tubulointerstitial inflammation. <i>Clin Sci (Lond).</i> 2017; <b>131</b>(1): 49–67. <a target=xrefwindow id=d16993e2357 href="http://www.ncbi.nlm.nih.gov/pubmed/27780843">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2360 href="http://dx.doi.org/10.1042/CS20160421">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d16993e2369 class=n-a></a>Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. <i>Am J Kidney Dis.</i> 1992; <b>20</b>(1): 1–17. <a target=xrefwindow id=d16993e2377 href="http://www.ncbi.nlm.nih.gov/pubmed/1621674">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2380 href="http://dx.doi.org/10.1016/S0272-6386(12)80312-X">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726141736"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e2389 class=n-a></a>Wolf BJ, Spainhour JC, Arthur JM, <i> et al.</i>: Development of Biomarker Models to Predict Outcomes in Lupus Nephritis. <i>Arthritis Rheumatol.</i> 2016; <b>68</b>(8): 1955–63. <a target=xrefwindow id=d16993e2400 href="http://www.ncbi.nlm.nih.gov/pubmed/26867033">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2403 href="http://dx.doi.org/10.1002/art.39623">Publisher Full Text </a> | <a target=xrefwindow id=d16993e2407 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5201110">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726141736">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726375724"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e2421 class=n-a></a>Wu T, Ding H, Han J, <i> et al.</i>: Antibody-Array-Based Proteomic Screening of Serum Markers in Systemic Lupus Erythematosus: A Discovery Study. <i>J Proteome Res.</i> 2016; <b>15</b>(7): 2102–14. <a target=xrefwindow id=d16993e2432 href="http://www.ncbi.nlm.nih.gov/pubmed/27211902">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2435 href="http://dx.doi.org/10.1021/acs.jproteome.5b00905">Publisher Full Text </a> | <a target=xrefwindow id=d16993e2439 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5193538">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726375724">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1012601"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e2452 class=n-a></a>Baechler EC, Batliwalla FM, Karypis G, <i> et al.</i>: Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. <i>Proc Natl Acad Sci U S A.</i> 2003; <b>100</b>(5): 2610–5. <a target=xrefwindow id=d16993e2463 href="http://www.ncbi.nlm.nih.gov/pubmed/12604793">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2466 href="http://dx.doi.org/10.1073/pnas.0337679100">Publisher Full Text </a> | <a target=xrefwindow id=d16993e2470 href="http://www.ncbi.nlm.nih.gov/pmc/articles/151388">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1012601">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d16993e2483 class=n-a></a>Nacionales DC, Kelly-Scumpia KM, Lee PY, <i> et al.</i>: Deficiency of the type I interferon receptor protects mice from experimental lupus. <i>Arthritis Rheum.</i> 2007; <b>56</b>(11): 3770–83. <a target=xrefwindow id=d16993e2494 href="http://www.ncbi.nlm.nih.gov/pubmed/17968932">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2497 href="http://dx.doi.org/10.1002/art.23023">Publisher Full Text </a> | <a target=xrefwindow id=d16993e2501 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2909118">Free Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d16993e2510 class=n-a></a>Mathian A, Weinberg A, Gallegos M, <i> et al.</i>: IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F<sub>1</sub> but not in BALB/c mice. <i>J Immunol.</i> 2005; <b>174</b>(5): 2499–506. <a target=xrefwindow id=d16993e2524 href="http://www.ncbi.nlm.nih.gov/pubmed/15728455">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2528 href="http://dx.doi.org/10.4049/jimmunol.174.5.2499">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d16993e2537 class=n-a></a>Fukuyama S, Kajiwara E, Suzuki N, <i> et al.</i>: Systemic lupus erythematosus after alpha-interferon therapy for chronic hepatitis C: a case report and review of the literature. <i>Am J Gastroenterol.</i> 2000; <b>95</b>(1): 310–2. <a target=xrefwindow id=d16993e2548 href="http://www.ncbi.nlm.nih.gov/pubmed/10638610">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2551 href="http://dx.doi.org/10.1111/j.1572-0241.2000.01715.x">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d16993e2560 class=n-a></a>Fairhurst AM, Xie C, Fu Y, <i> et al.</i>: Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis. <i>J Immunol.</i> 2009; <b>183</b>(10): 6831–8. <a target=xrefwindow id=d16993e2571 href="http://www.ncbi.nlm.nih.gov/pubmed/19864599">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2574 href="http://dx.doi.org/10.4049/jimmunol.0900742">Publisher Full Text </a> | <a target=xrefwindow id=d16993e2578 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2876821">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d16993e2588 class=n-a></a>Anders HJ, Schlöndorff D: Toll-like receptors: emerging concepts in kidney disease. <i>Curr Opin Nephrol Hypertens.</i> 2007; <b>16</b>(3): 177–83. <a target=xrefwindow id=d16993e2596 href="http://www.ncbi.nlm.nih.gov/pubmed/17420659">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2599 href="http://dx.doi.org/10.1097/MNH.0b013e32803fb767">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d16993e2608 class=n-a></a>Zhang X, Han X, Tang Y, <i> et al.</i>: miR-744 enhances type I interferon signaling pathway by targeting PTP1B in primary human renal mesangial cells. <i>Sci Rep.</i> 2015; <b>5</b>: 12987. <a target=xrefwindow id=d16993e2619 href="http://www.ncbi.nlm.nih.gov/pubmed/26259828">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2622 href="http://dx.doi.org/10.1038/srep12987">Publisher Full Text </a> | <a target=xrefwindow id=d16993e2626 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4531339">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726310584"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e2635 class=n-a></a>Han X, Wang Y, Zhang X, <i> et al.</i>: MicroRNA-130b Ameliorates Murine Lupus Nephritis Through Targeting the Type I Interferon Pathway on Renal Mesangial Cells. <i>Arthritis Rheumatol.</i> 2016; <b>68</b>(9): 2232–43. <a target=xrefwindow id=d16993e2646 href="http://www.ncbi.nlm.nih.gov/pubmed/27111096">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2649 href="http://dx.doi.org/10.1002/art.39725">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726310584">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d16993e2662 class=n-a></a>Bergtold A, Gavhane A, D'Agati V, <i> et al.</i>: FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis. <i>J Immunol.</i> 2006; <b>177</b>(10): 7287–95. <a target=xrefwindow id=d16993e2673 href="http://www.ncbi.nlm.nih.gov/pubmed/17082647">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2676 href="http://dx.doi.org/10.4049/jimmunol.177.10.7287 ">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d16993e2685 class=n-a></a>Crow MK: Advances in understanding the role of type I interferons in systemic lupus erythematosus. <i>Curr Opin Rheumatol.</i> 2014; <b>26</b>(5): 467–74. <a target=xrefwindow id=d16993e2693 href="http://www.ncbi.nlm.nih.gov/pubmed/25010440">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2696 href="http://dx.doi.org/10.1097/BOR.0000000000000087">Publisher Full Text </a> | <a target=xrefwindow id=d16993e2699 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4280994">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d16993e2708 class=n-a></a>Richards HB, Satoh M, Shaw M, <i> et al.</i>: Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. <i>J Exp Med.</i> 1998; <b>188</b>(5): 985–90. <a target=xrefwindow id=d16993e2719 href="http://www.ncbi.nlm.nih.gov/pubmed/9730900">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2722 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2213386">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d16993e2732 class=n-a></a>Tesch GH, Maifert S, Schwarting A, <i> et al.</i>: Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-<i>Fas</i><sup>lpr</sup> mice. <i>J Exp Med.</i> 1999; <b>190</b>(12): 1813–24. <a target=xrefwindow id=d16993e2748 href="http://www.ncbi.nlm.nih.gov/pubmed/10601356">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2752 href="http://dx.doi.org/10.1084/jem.190.12.1813">Publisher Full Text </a> | <a target=xrefwindow id=d16993e2755 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2195716">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726275735"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e2764 class=n-a></a>Kang S, Rogers JL, Monteith AJ, <i> et al.</i>: Apoptotic Debris Accumulates on Hematopoietic Cells and Promotes Disease in Murine and Human Systemic Lupus Erythematosus. <i>J Immunol.</i> 2016; <b>196</b>(10): 4030–9. <a target=xrefwindow id=d16993e2775 href="http://www.ncbi.nlm.nih.gov/pubmed/27059595">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2778 href="http://dx.doi.org/10.4049/jimmunol.1500418">Publisher Full Text </a> | <a target=xrefwindow id=d16993e2782 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4868781">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726275735">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d16993e2795 class=n-a></a>Li Y, Lee PY, Sobel ES, <i> et al.</i>: Increased expression of Fc<i>gamma</i>RI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus. <i>Arthritis Res Ther.</i> 2009; <b>11</b>(1): R6. <a target=xrefwindow id=d16993e2809 href="http://www.ncbi.nlm.nih.gov/pubmed/19144150">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2813 href="http://dx.doi.org/10.1186/ar2590">Publisher Full Text </a> | <a target=xrefwindow id=d16993e2816 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2688236">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1002599"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e2825 class=n-a></a>Blanco P, Palucka AK, Gill M, <i> et al.</i>: Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. <i>Science.</i> 2001; <b>294</b>(5546): 1540–3. <a target=xrefwindow id=d16993e2836 href="http://www.ncbi.nlm.nih.gov/pubmed/11711679">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2839 href="http://dx.doi.org/10.1126/science.1064890">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1002599">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726445671"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e2852 class=n-a></a>Mavragani CP, Sagalovskiy I, Guo Q, <i> et al.</i>: Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease. <i>Arthritis Rheumatol.</i> 2016; <b>68</b>(11): 2686–96. <a target=xrefwindow id=d16993e2863 href="http://www.ncbi.nlm.nih.gov/pubmed/27338297">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2866 href="http://dx.doi.org/10.1002/art.39795">Publisher Full Text </a> | <a target=xrefwindow id=d16993e2870 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5083133">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726445671">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727054405"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e2883 class=n-a></a>Buskiewicz IA, Montgomery T, Yasewicz EC, <i> et al.</i>: Reactive oxygen species induce virus-independent MAVS oligomerization in systemic lupus erythematosus. <i>Sci Signal.</i> 2016; <b>9</b>(456): ra115. <a target=xrefwindow id=d16993e2894 href="http://www.ncbi.nlm.nih.gov/pubmed/27899525">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2897 href="http://dx.doi.org/10.1126/scisignal.aaf1933">Publisher Full Text </a> | <a target=xrefwindow id=d16993e2901 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5321043">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727054405">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726406819"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e2915 class=n-a></a>Zhuang H, Han S, Li Y, <i> et al.</i>: A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM. <i>Arthritis Rheumatol.</i> 2016; <b>68</b>(12): 2917–28. <a target=xrefwindow id=d16993e2926 href="http://www.ncbi.nlm.nih.gov/pubmed/27274010">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2929 href="http://dx.doi.org/10.1002/art.39781">Publisher Full Text </a> | <a target=xrefwindow id=d16993e2933 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5125898">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726406819">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d16993e2946 class=n-a></a>Nishimoto N, Kishimoto T: Interleukin 6: from bench to bedside. <i>Nat Clin Pract Rheumatol.</i> 2006; <b>2</b>(11): 619–26. <a target=xrefwindow id=d16993e2954 href="http://www.ncbi.nlm.nih.gov/pubmed/17075601">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2957 href="http://dx.doi.org/10.1038/ncprheum0338">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d16993e2966 class=n-a></a>Soliman S, Mohan C: Lupus nephritis biomarkers. <i>Clin Immunol.</i> 2016; pii: S1521-6616(16)30257-1. <a target=xrefwindow id=d16993e2971 href="http://www.ncbi.nlm.nih.gov/pubmed/27498110">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2974 href="http://dx.doi.org/10.1016/j.clim.2016.08.001">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d16993e2983 class=n-a></a>Duffield JS: Macrophages and immunologic inflammation of the kidney. <i>Semin Nephrol.</i> 2010; <b>30</b>(3): 234–54. <a target=xrefwindow id=d16993e2991 href="http://www.ncbi.nlm.nih.gov/pubmed/20620669">PubMed Abstract </a> | <a target=xrefwindow id=d16993e2994 href="http://dx.doi.org/10.1016/j.semnephrol.2010.03.003">Publisher Full Text </a> | <a target=xrefwindow id=d16993e2997 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2922007">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d16993e3006 class=n-a></a>Davidson A, Bethunaickan R, Berthier C, <i> et al.</i>: Molecular studies of lupus nephritis kidneys. <i>Immunol Res.</i> 2015; <b>63</b>(1–3): 187–96. <a target=xrefwindow id=d16993e3017 href="http://www.ncbi.nlm.nih.gov/pubmed/26376897">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3020 href="http://dx.doi.org/10.1007/s12026-015-8693-6">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d16993e3029 class=n-a></a>Ricardo SD, van Goor H, Eddy AA: Macrophage diversity in renal injury and repair. <i>J Clin Invest.</i> 2008; <b>118</b>(11): 3522–30. <a target=xrefwindow id=d16993e3037 href="http://www.ncbi.nlm.nih.gov/pubmed/18982158">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3040 href="http://dx.doi.org/10.1172/JCI36150">Publisher Full Text </a> | <a target=xrefwindow id=d16993e3043 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2575702">Free Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718008452"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e3053 class=n-a></a>Wynn TA, Chawla A, Pollard JW: Macrophage biology in development, homeostasis and disease. <i>Nature.</i> 2013; <b>496</b>(7446): 445–55. <a target=xrefwindow id=d16993e3061 href="http://www.ncbi.nlm.nih.gov/pubmed/23619691">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3064 href="http://dx.doi.org/10.1038/nature12034">Publisher Full Text </a> | <a target=xrefwindow id=d16993e3067 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3725458">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718008452">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d16993e3080 class=n-a></a>Hill GS, Delahousse M, Nochy D, <i> et al.</i>: Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. <i>Kidney Int.</i> 2001; <b>59</b>(1): 304–16. <a target=xrefwindow id=d16993e3091 href="http://www.ncbi.nlm.nih.gov/pubmed/11135084">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3094 href="http://dx.doi.org/10.1046/j.1523-1755.2001.00492.x">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726308945"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e3103 class=n-a></a>Olmes G, Büttner-Herold M, Ferrazzi F, <i> et al.</i>: CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis. <i>Arthritis Res Ther.</i> 2016; <b>18</b>: 90. <a target=xrefwindow id=d16993e3114 href="http://www.ncbi.nlm.nih.gov/pubmed/27091114">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3117 href="http://dx.doi.org/10.1186/s13075-016-0989-y">Publisher Full Text </a> | <a target=xrefwindow id=d16993e3121 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4835936">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726308945">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d16993e3134 class=n-a></a>Zizzo G, Guerrieri J, Dittman LM, <i> et al.</i>: Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity. <i>Arthritis Res Ther.</i> 2013; <b>15</b>(6): R212. <a target=xrefwindow id=d16993e3145 href="http://www.ncbi.nlm.nih.gov/pubmed/24325951">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3148 href="http://dx.doi.org/10.1186/ar4407">Publisher Full Text </a> | <a target=xrefwindow id=d16993e3152 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3978923">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725296718"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e3161 class=n-a></a>Chalmers SA, Chitu V, Herlitz LC, <i> et al.</i>: Macrophage depletion ameliorates nephritis induced by pathogenic antibodies. <i>J Autoimmun.</i> 2015; <b>57</b>: 42–52. <a target=xrefwindow id=d16993e3172 href="http://www.ncbi.nlm.nih.gov/pubmed/25554644">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3175 href="http://dx.doi.org/10.1016/j.jaut.2014.11.007">Publisher Full Text </a> | <a target=xrefwindow id=d16993e3179 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4323927">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725296718">F1000 Recommendation</a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d16993e3192 class=n-a></a>Ikezumi Y, Suzuki T, Hayafuji S, <i> et al.</i>: The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis. <i>Nephrol Dial Transplant.</i> 2005; <b>20</b>(12): 2704–13. <a target=xrefwindow id=d16993e3203 href="http://www.ncbi.nlm.nih.gov/pubmed/16169862">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3206 href="http://dx.doi.org/10.1093/ndt/gfi105">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725308615"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e3216 class=n-a></a>Kinloch AJ, Chang A, Ko K, <i> et al.</i>: Vimentin is a dominant target of <i>in situ</i> humoral immunity in human lupus tubulointerstitial nephritis. <i>Arthritis Rheumatol.</i> 2014; <b>66</b>(12): 3359–70. <a target=xrefwindow id=d16993e3230 href="http://www.ncbi.nlm.nih.gov/pubmed/25306868">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3234 href="http://dx.doi.org/10.1002/art.38888">Publisher Full Text </a> | <a target=xrefwindow id=d16993e3237 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4264660">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725308615">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1013273"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e3250 class=n-a></a>Mor-Vaknin N, Punturieri A, Sitwala K, <i> et al.</i>: Vimentin is secreted by activated macrophages. <i>Nat Cell Biol.</i> 2003; <b>5</b>(1): 59–63. <a target=xrefwindow id=d16993e3261 href="http://www.ncbi.nlm.nih.gov/pubmed/12483219">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3264 href="http://dx.doi.org/10.1038/ncb898">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1013273">F1000 Recommendation</a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d16993e3277 class=n-a></a>Ise H, Goto M, Komura K, <i> et al.</i>: Engulfment and clearance of apoptotic cells based on a GlcNAc-binding lectin-like property of surface vimentin. <i>Glycobiology.</i> 2012; <b>22</b>(6): 788–805. <a target=xrefwindow id=d16993e3288 href="http://www.ncbi.nlm.nih.gov/pubmed/22345628">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3291 href="http://dx.doi.org/10.1093/glycob/cws052">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d16993e3300 class=n-a></a>Moisan E, Girard D: Cell surface expression of intermediate filament proteins vimentin and lamin B<sub>1</sub> in human neutrophil spontaneous apoptosis. <i>J Leukoc Biol.</i> 2006; <b>79</b>(3): 489–98. <a target=xrefwindow id=d16993e3311 href="http://www.ncbi.nlm.nih.gov/pubmed/16365157">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3314 href="http://dx.doi.org/10.1189/jlb.0405190">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d16993e3323 class=n-a></a>Bang H, Egerer K, Gauliard A, <i> et al.</i>: Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. <i>Arthritis Rheum.</i> 2007; <b>56</b>(8): 2503–11. <a target=xrefwindow id=d16993e3334 href="http://www.ncbi.nlm.nih.gov/pubmed/17665451">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3337 href="http://dx.doi.org/10.1002/art.22817">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d16993e3346 class=n-a></a>Besarani D, Cerundolo L, Smith JD, <i> et al.</i>: Role of anti-vimentin antibodies in renal transplantation. <i>Transplantation.</i> 2014; <b>98</b>(1): 72–8. <a target=xrefwindow id=d16993e3357 href="http://www.ncbi.nlm.nih.gov/pubmed/24978037">PubMed Abstract </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d16993e3367 class=n-a></a>Rose ML, Smith J, Dureau G, <i> et al.</i>: Mycophenolate mofetil decreases antibody production after cardiac transplantation. <i>J Heart Lung Transplant.</i> 2002; <b>21</b>(2): 282–5. <a target=xrefwindow id=d16993e3378 href="http://www.ncbi.nlm.nih.gov/pubmed/11834357">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3381 href="http://dx.doi.org/10.1016/S1053-2498(01)00335-7">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d16993e3390 class=n-a></a>Eddy AA: Molecular insights into renal interstitial fibrosis. <i>J Am Soc Nephrol.</i> 1996; <b>7</b>(12): 2495–508. <a target=xrefwindow id=d16993e3398 href="http://www.ncbi.nlm.nih.gov/pubmed/8989727">PubMed Abstract </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d16993e3407 class=n-a></a>Gharaee-Kermani M, Wiggins R, Wolber F, <i> et al.</i>: Fibronectin is the major fibroblast chemoattractant in rabbit anti-glomerular basement membrane disease. <i>Am J Pathol.</i> 1996; <b>148</b>(3): 961–7. <a target=xrefwindow id=d16993e3418 href="http://www.ncbi.nlm.nih.gov/pubmed/8774150">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3421 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1861713">Free Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d16993e3430 class=n-a></a>Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. <i>N Engl J Med.</i> 1994; <b>331</b>(19): 1286–92. <a target=xrefwindow id=d16993e3438 href="http://www.ncbi.nlm.nih.gov/pubmed/7935686">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3441 href="http://dx.doi.org/10.1056/NEJM199411103311907">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d16993e3450 class=n-a></a>Border WA, Noble NA, Yamamoto T, <i> et al.</i>: Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. <i>Nature.</i> 1992; <b>360</b>(6402): 361–4. <a target=xrefwindow id=d16993e3461 href="http://www.ncbi.nlm.nih.gov/pubmed/1280332">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3464 href="http://dx.doi.org/10.1038/360361a0">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d16993e3473 class=n-a></a>Liu Y: Renal fibrosis: new insights into the pathogenesis and therapeutics. <i>Kidney Int.</i> 2006; <b>69</b>(2): 213–7. <a target=xrefwindow id=d16993e3481 href="http://www.ncbi.nlm.nih.gov/pubmed/16408108">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3484 href="http://dx.doi.org/10.1038/sj.ki.5000054">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1040287"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e3494 class=n-a></a>Kim KK, Kugler MC, Wolters PJ, <i> et al.</i>: Alveolar epithelial cell mesenchymal transition develops <i>in vivo</i> during pulmonary fibrosis and is regulated by the extracellular matrix. <i>Proc Natl Acad Sci U S A.</i> 2006; <b>103</b>(35): 13180–5. <a target=xrefwindow id=d16993e3508 href="http://www.ncbi.nlm.nih.gov/pubmed/16924102">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3512 href="http://dx.doi.org/10.1073/pnas.0605669103">Publisher Full Text </a> | <a target=xrefwindow id=d16993e3515 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1551904">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1040287">F1000 Recommendation</a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d16993e3528 class=n-a></a>Friedman SL, Sheppard D, Duffield JS, <i> et al.</i>: Therapy for fibrotic diseases: nearing the starting line. <i>Sci Transl Med.</i> 2013; <b>5</b>(167): 167sr1. <a target=xrefwindow id=d16993e3539 href="http://www.ncbi.nlm.nih.gov/pubmed/23303606">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3542 href="http://dx.doi.org/10.1126/scitranslmed.3004700">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d16993e3551 class=n-a></a>Nakagawa N, Duffield JS: Myofibroblasts in Fibrotic Kidneys. <i>Curr Pathobiol Rep.</i> 2013; <b>1</b>(3): 189–198. <a target=xrefwindow id=d16993e3559 href="http://www.ncbi.nlm.nih.gov/pubmed/24187654">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3562 href="http://dx.doi.org/10.1007/s40139-013-0025-8">Publisher Full Text </a> | <a target=xrefwindow id=d16993e3565 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3810972">Free Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d16993e3574 class=n-a></a>Zhou H, Hasni SA, Perez P, <i> et al.</i>: miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. <i>J Am Soc Nephrol.</i> 2013; <b>24</b>(7): 1073–87. <a target=xrefwindow id=d16993e3585 href="http://www.ncbi.nlm.nih.gov/pubmed/23723424">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3588 href="http://dx.doi.org/10.1681/ASN.2012080849">Publisher Full Text </a> | <a target=xrefwindow id=d16993e3592 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3699828">Free Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725255914"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e3601 class=n-a></a>Kang HM, Ahn SH, Choi P, <i> et al.</i>: Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. <i>Nat Med.</i> 2015; <b>21</b>(1): 37–46. <a target=xrefwindow id=d16993e3612 href="http://www.ncbi.nlm.nih.gov/pubmed/25419705">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3615 href="http://dx.doi.org/10.1038/nm.3762">Publisher Full Text </a> | <a target=xrefwindow id=d16993e3619 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4444078">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725255914">F1000 Recommendation</a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d16993e3632 class=n-a></a>Dzik JM: Evolutionary roots of arginase expression and regulation. <i>Front Immunol.</i> 2014; <b>5</b>: 544. <a target=xrefwindow id=d16993e3640 href="http://www.ncbi.nlm.nih.gov/pubmed/25426114">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3643 href="http://dx.doi.org/10.3389/fimmu.2014.00544">Publisher Full Text </a> | <a target=xrefwindow id=d16993e3646 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4224125">Free Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d16993e3656 class=n-a></a>Duffield JS, Tipping PG, Kipari T, <i> et al.</i>: Conditional ablation of macrophages halts progression of crescentic glomerulonephritis. <i>Am J Pathol.</i> 2005; <b>167</b>(5): 1207–19. <a target=xrefwindow id=d16993e3667 href="http://www.ncbi.nlm.nih.gov/pubmed/16251406">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3670 href="http://dx.doi.org/10.1016/S0002-9440(10)61209-6">Publisher Full Text </a> | <a target=xrefwindow id=d16993e3674 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1603796">Free Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d16993e3683 class=n-a></a>Ko GJ, Boo CS, Jo SK, <i> et al.</i>: Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. <i>Nephrol Dial Transplant.</i> 2008; <b>23</b>(3): 842–52. <a target=xrefwindow id=d16993e3694 href="http://www.ncbi.nlm.nih.gov/pubmed/17984109">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3697 href="http://dx.doi.org/10.1093/ndt/gfm694">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d16993e3706 class=n-a></a>Ma FY, Liu J, Kitching AR, <i> et al.</i>: Targeting renal macrophage accumulation via c-<i>fms</i> kinase reduces tubular apoptosis but fails to modify progressive fibrosis in the obstructed rat kidney. <i>Am J Physiol Renal Physiol.</i> 2009; <b>296</b>(1): F177–85. <a target=xrefwindow id=d16993e3720 href="http://www.ncbi.nlm.nih.gov/pubmed/18987110">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3724 href="http://dx.doi.org/10.1152/ajprenal.90498.2008">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d16993e3733 class=n-a></a>Meng XM, Wang S, Huang XR, <i> et al.</i>: Inflammatory macrophages can transdifferentiate into myofibroblasts during renal fibrosis. <i>Cell Death Dis.</i> 2016; <b>7</b>(12): e2495. <a target=xrefwindow id=d16993e3744 href="http://www.ncbi.nlm.nih.gov/pubmed/27906172">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3747 href="http://dx.doi.org/10.1038/cddis.2016.402">Publisher Full Text </a> | <a target=xrefwindow id=d16993e3751 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5261004">Free Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d16993e3760 class=n-a></a>Campanholle G, Ligresti G, Gharib SA, <i> et al.</i>: Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis. <i>Am J Physiol Cell Physiol.</i> 2013; <b>304</b>(7): C591–603. <a target=xrefwindow id=d16993e3771 href="http://www.ncbi.nlm.nih.gov/pubmed/23325411">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3774 href="http://dx.doi.org/10.1152/ajpcell.00414.2012">Publisher Full Text </a> | <a target=xrefwindow id=d16993e3778 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3625718">Free Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1058809"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e3787 class=n-a></a>Takeji M, Moriyama T, Oseto S, <i> et al.</i>: Smooth muscle alpha-actin deficiency in myofibroblasts leads to enhanced renal tissue fibrosis. <i>J Biol Chem.</i> 2006; <b>281</b>(52): 40193–200. <a target=xrefwindow id=d16993e3798 href="http://www.ncbi.nlm.nih.gov/pubmed/17090535">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3801 href="http://dx.doi.org/10.1074/jbc.M602182200">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1058809">F1000 Recommendation</a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d16993e3815 class=n-a></a>Hahn BH, McMahon MA, Wilkinson A, <i> et al.</i>: American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. <i>Arthritis Care Res (Hoboken).</i> 2012; <b>64</b>(6): 797–808. <a target=xrefwindow id=d16993e3826 href="http://www.ncbi.nlm.nih.gov/pubmed/22556106">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3829 href="http://dx.doi.org/10.1002/acr.21664">Publisher Full Text </a> | <a target=xrefwindow id=d16993e3833 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3437757">Free Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d16993e3842 class=n-a></a>Bertsias GK, Tektonidou M, Amoura Z, <i> et al.</i>: Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. <i>Ann Rheum Dis.</i> 2012; <b>71</b>(11): 1771–82. <a target=xrefwindow id=d16993e3853 href="http://www.ncbi.nlm.nih.gov/pubmed/22851469">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3856 href="http://dx.doi.org/10.1136/annrheumdis-2012-201940">Publisher Full Text </a> | <a target=xrefwindow id=d16993e3860 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3465859">Free Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d16993e3869 class=n-a></a>Mok CC, Yap DY, Navarra SV, <i> et al.</i>: Overview of lupus nephritis management guidelines and perspective from Asia. <i>Nephrology (Carlton).</i> 2014; <b>19</b>(1): 11–20. <a target=xrefwindow id=d16993e3880 href="http://www.ncbi.nlm.nih.gov/pubmed/23876069">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3883 href="http://dx.doi.org/10.1111/nep.12136">Publisher Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d16993e3892 class=n-a></a>KDIGO Clinical Practice Guideline for Glomerulonephritis: Chapter 12: Lupus nephritis. <i>Kidney Int Suppl (2011).</i> 2012; <b>2</b>(2): 221–32. <a target=xrefwindow id=d16993e3900 href="http://www.ncbi.nlm.nih.gov/pubmed/25018937">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3903 href="http://dx.doi.org/10.1038/kisup.2012.25">Publisher Full Text </a> | <a target=xrefwindow id=d16993e3906 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4089588">Free Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d16993e3915 class=n-a></a>Chan TM, Li FK, Tang CS, <i> et al.</i>: Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. <i>N Engl J Med.</i> 2000; <b>343</b>(16): 1156–62. <a target=xrefwindow id=d16993e3926 href="http://www.ncbi.nlm.nih.gov/pubmed/11036121">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3929 href="http://dx.doi.org/10.1056/NEJM200010193431604">Publisher Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d16993e3938 class=n-a></a>Illei GG, Austin HA, Crane M, <i> et al.</i>: Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. <i>Ann Intern Med.</i> 2001; <b>135</b>(4): 248–57. <a target=xrefwindow id=d16993e3949 href="http://www.ncbi.nlm.nih.gov/pubmed/11511139">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3952 href="http://dx.doi.org/10.7326/0003-4819-135-4-200108210-00009">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d16993e3962 class=n-a></a>Contreras G, Pardo V, Leclercq B, <i> et al.</i>: Sequential therapies for proliferative lupus nephritis. <i>N Engl J Med.</i> 2004; <b>350</b>(10): 971–80. <a target=xrefwindow id=d16993e3973 href="http://www.ncbi.nlm.nih.gov/pubmed/14999109">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3976 href="http://dx.doi.org/10.1056/NEJMoa031855">Publisher Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d16993e3985 class=n-a></a>Nishida M, Okumura Y, Fujimoto S, <i> et al.</i>: Adoptive transfer of macrophages ameliorates renal fibrosis in mice. <i>Biochem Biophys Res Commun.</i> 2005; <b>332</b>(1): 11–6. <a target=xrefwindow id=d16993e3996 href="http://www.ncbi.nlm.nih.gov/pubmed/15896292">PubMed Abstract </a> | <a target=xrefwindow id=d16993e3999 href="http://dx.doi.org/10.1016/j.bbrc.2005.04.083">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d16993e4008 class=n-a></a>Johnson WW, Meadows DC: Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy. <i>N Engl J Med.</i> 1971; <b>284</b>(6): 290–4. <a target=xrefwindow id=d16993e4016 href="http://www.ncbi.nlm.nih.gov/pubmed/4321778">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4019 href="http://dx.doi.org/10.1056/NEJM197102112840602">Publisher Full Text </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d16993e4028 class=n-a></a>Naesens M, Kuypers DR, Sarwal M: Calcineurin inhibitor nephrotoxicity. <i>Clin J Am Soc Nephrol.</i> 2009; <b>4</b>(2): 481–508. <a target=xrefwindow id=d16993e4036 href="http://www.ncbi.nlm.nih.gov/pubmed/19218475">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4039 href="http://dx.doi.org/10.2215/CJN.04800908">Publisher Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d16993e4048 class=n-a></a>Tse KC, Li FK, Tang S, <i> et al.</i>: Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria. <i>Lupus.</i> 2005; <b>14</b>(12): 947–52. <a target=xrefwindow id=d16993e4059 href="http://www.ncbi.nlm.nih.gov/pubmed/16425574">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4062 href="http://dx.doi.org/10.1191/0961203305lu2249oa">Publisher Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d16993e4071 class=n-a></a>De Albuquerque DA, Saxena V, Adams DE, <i> et al.</i>: An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis. <i>Kidney Int.</i> 2004; <b>65</b>(3): 846–59. <a target=xrefwindow id=d16993e4082 href="http://www.ncbi.nlm.nih.gov/pubmed/14871404">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4085 href="http://dx.doi.org/10.1111/j.1523-1755.2004.00462.x">Publisher Full Text </a> | <a target=xrefwindow id=d16993e4089 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2291513">Free Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d16993e4099 class=n-a></a>Buttgereit F, Wehling M, Burmester GR: A new hypothesis of modular glucocorticoid actions: steroid treatment of rheumatic diseases revisited. <i>Arthritis Rheum.</i> 1998; <b>41</b>(5): 761–7. <a target=xrefwindow id=d16993e4107 href="http://www.ncbi.nlm.nih.gov/pubmed/9588727">PubMed Abstract </a> | <a target="xrefwindow" id="d16993e4110" href="http://dx.doi.org/10.1002/1529-0131(199805)41:5<761::AID-ART2&gt;3.0.CO;2-M">Publisher Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d16993e4119 class=n-a></a>Youssef PP, Haynes DR, Triantafillou S, <i> et al.</i>: Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis. <i>Arthritis Rheum.</i> 1997; <b>40</b>(8): 1400–8. <a target=xrefwindow id=d16993e4130 href="http://www.ncbi.nlm.nih.gov/pubmed/9259419">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4133 href="http://dx.doi.org/10.1002/art.1780400807">Publisher Full Text </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d16993e4142 class=n-a></a>Yokoyama H, Takabatake T, Takaeda M, <i> et al.</i>: Up-regulated MHC-class II expression and gamma-IFN and soluble IL-2R in lupus nephritis. <i>Kidney Int.</i> 1992; <b>42</b>(3): 755–63. <a target=xrefwindow id=d16993e4153 href="http://www.ncbi.nlm.nih.gov/pubmed/1405353">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4156 href="http://dx.doi.org/10.1038/ki.1992.344">Publisher Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8909956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e4165 class=n-a></a>Navarra SV, Guzmán RM, Gallacher AE, <i> et al.</i>: Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. <i>Lancet.</i> 2011; <b>377</b>(9767): 721–31. <a target=xrefwindow id=d16993e4176 href="http://www.ncbi.nlm.nih.gov/pubmed/21296403">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4179 href="http://dx.doi.org/10.1016/S0140-6736(10)61354-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8909956">F1000 Recommendation</a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d16993e4192 class=n-a></a>Furie R, Petri M, Zamani O, <i> et al.</i>: A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. <i>Arthritis Rheum.</i> 2011; <b>63</b>(12): 3918–30. <a target=xrefwindow id=d16993e4203 href="http://www.ncbi.nlm.nih.gov/pubmed/22127708">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4206 href="http://dx.doi.org/10.1002/art.30613">Publisher Full Text </a> | <a target=xrefwindow id=d16993e4210 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5007058">Free Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d16993e4219 class=n-a></a>Dooley MA, Houssiau F, Aranow C, <i> et al.</i>: Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE. <i>Lupus.</i> 2013; <b>22</b>(1): 63–72. <a target=xrefwindow id=d16993e4230 href="http://www.ncbi.nlm.nih.gov/pubmed/23263865">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4233 href="http://dx.doi.org/10.1177/0961203312465781">Publisher Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/716597855"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e4243 class=n-a></a>Rovin BH, Furie R, Latinis K, <i> et al.</i>: Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. <i>Arthritis Rheum.</i> 2012; <b>64</b>(4): 1215–26. <a target=xrefwindow id=d16993e4254 href="http://www.ncbi.nlm.nih.gov/pubmed/22231479">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4257 href="http://dx.doi.org/10.1002/art.34359">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/716597855">F1000 Recommendation</a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a name=d16993e4270 class=n-a></a>Furie R, Nicholls K, Cheng TT, <i> et al.</i>: Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study. <i>Arthritis Rheumatol.</i> 2014; <b>66</b>(2): 379–89. <a target=xrefwindow id=d16993e4281 href="http://www.ncbi.nlm.nih.gov/pubmed/24504810">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4284 href="http://dx.doi.org/10.1002/art.38260">Publisher Full Text </a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d16993e4293 class=n-a></a>Ramanujam M, Bethunaickan R, Huang W, <i> et al.</i>: Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice. <i>Arthritis Rheum.</i> 2010; <b>62</b>(5): 1457–68. <a target=xrefwindow id=d16993e4304 href="http://www.ncbi.nlm.nih.gov/pubmed/20131293">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4307 href="http://dx.doi.org/10.1002/art.27368">Publisher Full Text </a> | <a target=xrefwindow id=d16993e4311 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2917190">Free Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d16993e4320 class=n-a></a>Schiffer L, Sinha J, Wang X, <i> et al.</i>: Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F<sub>1</sub> mice by a mechanism downstream of renal immune complex deposition. <i>J Immunol.</i> 2003; <b>171</b>(1): 489–97. <a target=xrefwindow id=d16993e4334 href="http://www.ncbi.nlm.nih.gov/pubmed/12817034">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4338 href="http://dx.doi.org/10.4049/jimmunol.171.1.489">Publisher Full Text </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a name=d16993e4347 class=n-a></a>Linker-Israeli M, Deans RJ, Wallace DJ, <i> et al.</i>: Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. <i>J Immunol.</i> 1991; <b>147</b>(1): 117–23. <a target=xrefwindow id=d16993e4358 href="http://www.ncbi.nlm.nih.gov/pubmed/2051017">PubMed Abstract </a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d16993e4367 class=n-a></a>Liang B, Gardner DB, Griswold DE, <i> et al.</i>: Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus. <i>Immunology.</i> 2006; <b>119</b>(3): 296–305. <a target=xrefwindow id=d16993e4378 href="http://www.ncbi.nlm.nih.gov/pubmed/17067309">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4381 href="http://dx.doi.org/10.1111/j.1365-2567.2006.02433.x">Publisher Full Text </a> | <a target=xrefwindow id=d16993e4385 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1819578">Free Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726310595"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e4395 class=n-a></a>Rovin BH, van Vollenhoven RF, Aranow C, <i> et al.</i>: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis. <i>Arthritis Rheumatol.</i> 2016; <b>68</b>(9): 2174–83. <a target=xrefwindow id=d16993e4406 href="http://www.ncbi.nlm.nih.gov/pubmed/27110697">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4409 href="http://dx.doi.org/10.1002/art.39722">Publisher Full Text </a> | <a target=xrefwindow id=d16993e4413 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5129491">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726310595">F1000 Recommendation</a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a name=d16993e4426 class=n-a></a>Michaelson JS, Wisniacki N, Burkly LC, <i> et al.</i>: Role of TWEAK in lupus nephritis: a bench-to-bedside review. <i>J Autoimmun.</i> 2012; <b>39</b>(3): 130–42. <a target=xrefwindow id=d16993e4437 href="http://www.ncbi.nlm.nih.gov/pubmed/22727560">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4440 href="http://dx.doi.org/10.1016/j.jaut.2012.05.003">Publisher Full Text </a> | <a target=xrefwindow id=d16993e4444 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3428508">Free Full Text </a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d16993e4453 class=n-a></a>Zhao Z, Burkly LC, Campbell S, <i> et al.</i>: TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus. <i>J Immunol.</i> 2007; <b>179</b>(11): 7949–58. <a target=xrefwindow id=d16993e4464 href="http://www.ncbi.nlm.nih.gov/pubmed/18025243">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4467 href="http://dx.doi.org/10.4049/jimmunol.179.11.7949">Publisher Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a name=d16993e4476 class=n-a></a>Molano A, Lakhani P, Aran A, <i> et al.</i>: TWEAK stimulation of kidney resident cells in the pathogenesis of graft versus host induced lupus nephritis. <i>Immunol Lett.</i> 2009; <b>125</b>(2): 119–28. <a target=xrefwindow id=d16993e4487 href="http://www.ncbi.nlm.nih.gov/pubmed/19573558">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4490 href="http://dx.doi.org/10.1016/j.imlet.2009.06.010">Publisher Full Text </a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726989983"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e4499 class=n-a></a>Furie R, Khamashta M, Merrill JT, <i> et al.</i>: Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus. <i>Arthritis Rheumatol.</i> 2017; <b>69</b>(2): 376–86. <a target=xrefwindow id=d16993e4510 href="http://www.ncbi.nlm.nih.gov/pubmed/28130918">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4513 href="http://dx.doi.org/10.1002/art.39962">Publisher Full Text </a> | <a target=xrefwindow id=d16993e4517 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5299497">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726989983">F1000 Recommendation</a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d16993e4530 class=n-a></a>ACCESS Trial Group: Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study. <i>Arthritis Rheumatol.</i> 2014; <b>66</b>(11): 3096–104. <a target=xrefwindow id=d16993e4538 href="http://www.ncbi.nlm.nih.gov/pubmed/25403681">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4541 href="http://dx.doi.org/10.1002/art.38790">Publisher Full Text </a> | <a target=xrefwindow id=d16993e4544 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4528976">Free Full Text </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717971077"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d16993e4554 class=n-a></a>Wofsy D, Hillson JL, Diamond B: Abatacept for lupus nephritis: alternative definitions of complete response support conflicting conclusions. <i>Arthritis Rheum.</i> 2012; <b>64</b>(11): 3660–5. <a target=xrefwindow id=d16993e4562 href="http://www.ncbi.nlm.nih.gov/pubmed/22806274">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4565 href="http://dx.doi.org/10.1002/art.34624">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717971077">F1000 Recommendation</a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a name=d16993e4578 class=n-a></a>Hahn BH, Kono D: Animal models of SLE. In: Wallace DJ, Hahn BH, eds. <i>Dubois' Lupus Erythematosus and Related Syndromes</i>. 8th ed. Philadelphia: Elsevier Saunders; 2013; 190–236. <a target=xrefwindow id=d16993e4583 href="http://dx.doi.org/10.1016/B978-1-4377-1893-5.00017-0">Publisher Full Text </a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a name=d16993e4592 class=n-a></a>Blatt NB, Glick GD: Anti-DNA autoantibodies and systemic lupus erythematosus. <i>Pharmacol Ther.</i> 1999; <b>83</b>(2): 125–39. <a target=xrefwindow id=d16993e4600 href="http://www.ncbi.nlm.nih.gov/pubmed/10511458">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4603 href="http://dx.doi.org/10.1016/S0163-7258(99)00022-4">Publisher Full Text </a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a name=d16993e4612 class=n-a></a>Grande JP: Experimental models of lupus nephritis. <i>Contrib Nephrol.</i> 2011; <b>169</b>: 183–97. <a target=xrefwindow id=d16993e4620 href="http://www.ncbi.nlm.nih.gov/pubmed/21252519">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4623 href="http://dx.doi.org/10.1159/000319241">Publisher Full Text </a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a name=d16993e4632 class=n-a></a>Ge Y, Jiang C, Sung SJ, <i> et al.</i>: <i>Cgnz1</i> allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis. <i>J Exp Med.</i> 2013; <b>210</b>(11): 2387–401. <a target=xrefwindow id=d16993e4646 href="http://www.ncbi.nlm.nih.gov/pubmed/24101379">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4650 href="http://dx.doi.org/10.1084/jem.20130731">Publisher Full Text </a> | <a target=xrefwindow id=d16993e4653 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3804943">Free Full Text </a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a name=d16993e4662 class=n-a></a>Li L, Nukala S, Du Y, <i> et al.</i>: Murine lupus strains differentially model unique facets of human lupus serology. <i>Clin Exp Immunol.</i> 2012; <b>168</b>(2): 178–85. <a target=xrefwindow id=d16993e4673 href="http://www.ncbi.nlm.nih.gov/pubmed/22471278">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4676 href="http://dx.doi.org/10.1111/j.1365-2249.2012.04568.x">Publisher Full Text </a> | <a target=xrefwindow id=d16993e4680 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3390518">Free Full Text </a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d16993e4690 class=n-a></a>Murphy ED, Roths JB: A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. <i>Arthritis Rheum.</i> 1979; <b>22</b>(11): 1188–94. <a target=xrefwindow id=d16993e4698 href="http://www.ncbi.nlm.nih.gov/pubmed/315777">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4701 href="http://dx.doi.org/10.1002/art.1780221105">Publisher Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a name=d16993e4710 class=n-a></a>Reeves WH, Lee PY, Weinstein JS, <i> et al.</i>: Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. <i>Trends Immunol.</i> 2009; <b>30</b>(9): 455–64. <a target=xrefwindow id=d16993e4721 href="http://www.ncbi.nlm.nih.gov/pubmed/19699150">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4724 href="http://dx.doi.org/10.1016/j.it.2009.06.003">Publisher Full Text </a> | <a target=xrefwindow id=d16993e4728 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2746238">Free Full Text </a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a name=d16993e4737 class=n-a></a>Satoh M, Kumar A, Kanwar YS, <i> et al.</i>: Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. <i>Proc Natl Acad Sci U S A.</i> 1995; <b>92</b>(24): 10934–8. <a target=xrefwindow id=d16993e4748 href="http://www.ncbi.nlm.nih.gov/pubmed/7479913">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4751 href="http://dx.doi.org/10.1073/pnas.92.24.10934">Publisher Full Text </a> | <a target=xrefwindow id=d16993e4755 href="http://www.ncbi.nlm.nih.gov/pmc/articles/40545">Free Full Text </a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d16993e4764 class=n-a></a>Xu Y, Zeumer L, Reeves WH, <i> et al.</i>: Induced murine models of systemic lupus erythematosus. <i>Methods Mol Biol.</i> 2014; <b>1134</b>: 103–30. <a target=xrefwindow id=d16993e4775 href="http://www.ncbi.nlm.nih.gov/pubmed/24497358">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4778 href="http://dx.doi.org/10.1007/978-1-4939-0326-9_9">Publisher Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a name=d16993e4787 class=n-a></a>McGaha TL, Madaio MP: Lupus Nephritis: Animal Modeling of a Complex Disease Syndrome Pathology. <i>Drug Discov Today Dis Models.</i> 2014; <b>11</b>: 13–8. <a target=xrefwindow id=d16993e4795 href="http://www.ncbi.nlm.nih.gov/pubmed/25722732">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4798 href="http://dx.doi.org/10.1016/j.ddmod.2014.08.002">Publisher Full Text </a> | <a target=xrefwindow id=d16993e4801 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4337231">Free Full Text </a></span></li><li><a name=ref-137 class=n-a></a><span class=label>137. </span>&nbsp;<span class=citation><a name=d16993e4810 class=n-a></a>Bergijk EC, Munaut C, Baelde JJ, <i> et al.</i>: A histologic study of the extracellular matrix during the development of glomerulosclerosis in murine chronic graft-versus-host disease. <i>Am J Pathol.</i> 1992; <b>140</b>(5): 1147–56. <a target=xrefwindow id=d16993e4821 href="http://www.ncbi.nlm.nih.gov/pubmed/1580327">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4824 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1886501">Free Full Text </a></span></li><li><a name=ref-138 class=n-a></a><span class=label>138. </span>&nbsp;<span class=citation><a name=d16993e4834 class=n-a></a>Bruijn JA, van Elven EH, Hogendoorn PC, <i> et al.</i>: Murine chronic graft-versus-host disease as a model for lupus nephritis. <i>Am J Pathol.</i> 1988; <b>130</b>(3): 639–41. <a target=xrefwindow id=d16993e4845 href="http://www.ncbi.nlm.nih.gov/pubmed/3279795">PubMed Abstract </a> | <a target=xrefwindow id=d16993e4848 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1880687">Free Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 13 Jun 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-874.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-874.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Medicine, University of Hong Kong, Hong Kong, Hong Kong<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-874/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 13 Jun 2017, 6:874 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.10445.1">https://doi.org/10.12688/f1000research.10445.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Yung S <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=11255 data-id=10445 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10445.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-874/v1/pdf?article_uuid=cec0a1fd-1661-4ff5-9835-797f9b49da49" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.10445.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Yung S, Yap DY and Chan TM. Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):874 (<a href="https://doi.org/10.12688/f1000research.10445.1" target=_blank>https://doi.org/10.12688/f1000research.10445.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=10445 id=mobile-track-article-signin-10445 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10445?target=/articles/6-874.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=11255 /> <input name=articleId type=hidden value=10445 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Anne Davidson</strong>, Feinstein Institute, Center for Autoimmunity and Musculoskeletal Diseases, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Chaim Putterman</strong>, Department of Medicine, Albert Einstein College of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 13 Jun 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-874.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-874.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=23568-23440></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=10890-23441></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-874/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>13 Jun 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Anne Davidson</strong>, Feinstein Institute, Center for Autoimmunity and Musculoskeletal Diseases, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Chaim Putterman</strong>, Department of Medicine, Albert Einstein College of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-874.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-874/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in the understanding of renal...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-874/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-874/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-874/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Yung S et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-874/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-874",
            templates : {
                twitter : "Recent advances in the understanding of renal inflammation and.... Yung S et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-874/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/10445/11255")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "11255");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "23440": 0,
                           "23441": 0,
                           "23442": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "4860b20c-134e-4831-8d68-74617166fb2e";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-874.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-874.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-874.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-874.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-874.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>